{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 1228, "items": [{"indexed": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T19:04:14Z", "timestamp": 1576695854787}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Research"], "published-print": {"date-parts": [[2009, 6, 15]]}, "DOI": "10.1158/0008-5472.can-09-0547", "type": "journal-article", "created": {"date-parts": [[2009, 6, 10]], "date-time": "2009-06-10T05:34:36Z", "timestamp": 1244612076000}, "page": "4941-4944", "source": "Crossref", "is-referenced-by-count": 289, "title": ["Bispecific T-Cell Engaging Antibodies for Cancer Therapy"], "prefix": "10.1158", "volume": "69", "author": [{"given": "P. A.", "family": "Baeuerle", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "Reinhardt", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2009, 6, 9]]}, "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.CAN-09-0547", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T14:34:49Z", "timestamp": 1482503689000}, "score": 57.29196, "issued": {"date-parts": [[2009, 6, 9]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2009, 6, 15]]}, "published-print": {"date-parts": [[2009, 6, 15]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.1158/0008-5472.can-09-0547", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T10:16:04Z", "timestamp": 1575195364518}, "reference-count": 50, "publisher": "CRC Press", "isbn-type": [{"value": "9781841848297", "type": "print"}, {"value": "9781841848303", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011, 8, 23]]}, "DOI": "10.3109/9781841848303-19", "type": "book-chapter", "created": {"date-parts": [[2013, 3, 5]], "date-time": "2013-03-05T08:59:24Z", "timestamp": 1362473964000}, "page": "250-262", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Passive immunotherapy by T cell\u2013engaging bispecific antibodies"], "prefix": "10.3109", "author": [{"given": "Patrick", "family": "Baeuerle", "sequence": "first", "affiliation": []}, {"given": "Benno", "family": "Rattel", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2013, 3, 4]]}, "reference": [{"key": "p_1", "DOI": "10.1126/science.8171337", "doi-asserted-by": "publisher"}, {"key": "p_2", "author": "Altenschmidt U", "volume": "159", "first-page": "5509", "year": "1997", "journal-title": "J Immunol"}, {"key": "p_3", "DOI": "10.1016/j.molimm.2005.07.034", "doi-asserted-by": "publisher"}, {"key": "p_4", "DOI": "10.1073/pnas.0813101106", "doi-asserted-by": "publisher"}, {"key": "p_5", "DOI": "10.1007/s00262-008-0653-8", "doi-asserted-by": "publisher"}, {"key": "p_6", "DOI": "10.1056/NEJMoa020177", "doi-asserted-by": "publisher"}, {"key": "p_7", "DOI": "10.1056/NEJMoa051424", "doi-asserted-by": "publisher"}, {"key": "p_8", "DOI": "10.1158/1078-0432.CCR-06-1734", "doi-asserted-by": "publisher"}, {"key": "p_9", "DOI": "10.1146/annurev.immunol.25.022106.141609", "doi-asserted-by": "publisher"}, {"key": "p_10", "DOI": "10.1038/314628a0", "doi-asserted-by": "publisher"}, {"key": "p_11", "author": "M\u00fcller D", "volume": "9", "first-page": "319", "year": "2007", "journal-title": "Curr Opin Mol Ther"}, {"key": "p_12", "DOI": "10.1016/j.ctrv.2010.03.001", "doi-asserted-by": "publisher"}, {"key": "p_13", "DOI": "10.1111/j.1365-2125.2010.03635.x", "doi-asserted-by": "publisher"}, {"key": "p_14", "author": "Lindhofer H", "volume": "155", "first-page": "219", "year": "1995", "journal-title": "J Immunol"}, {"key": "p_15", "DOI": "10.1007/s00262-010-0894-1", "doi-asserted-by": "publisher"}, {"key": "p_16", "DOI": "10.1007/s00262-007-0310-7", "doi-asserted-by": "publisher"}, {"key": "p_17", "author": "Fiedler WM", "volume": "28", "first-page": "2573", "year": "2010", "journal-title": "J Clin Oncol", "DOI": "10.1200/jco.2010.28.15_suppl.2573", "doi-asserted-by": "crossref"}, {"key": "p_18", "DOI": "10.1158/1078-0432.CCR-05-2436", "doi-asserted-by": "publisher"}, {"key": "p_19", "DOI": "10.1038/bmt.2008.323", "doi-asserted-by": "publisher"}, {"key": "p_20", "DOI": "10.1186/1756-9966-28-18", "doi-asserted-by": "publisher"}, {"key": "p_21", "DOI": "10.1016/S1473-3099(02)00222-0", "doi-asserted-by": "publisher"}, {"key": "p_22", "DOI": "10.1517/14712590903575620", "doi-asserted-by": "publisher"}, {"key": "p_23", "DOI": "10.1054/bjoc.2001.1891", "doi-asserted-by": "publisher"}, {"key": "p_24", "DOI": "10.1200/JCO.2004.12.034", "doi-asserted-by": "publisher"}, {"key": "p_25", "DOI": "10.1200/JCO.2008.20.2515", "doi-asserted-by": "publisher"}, {"key": "p_26", "DOI": "10.1038/sj.bjc.6603567", "doi-asserted-by": "publisher"}, {"key": "p_27", "DOI": "10.1097/CJI.0b013e3181d75820", "doi-asserted-by": "publisher"}, {"key": "p_28", "DOI": "10.1158/0008-5472.CAN-09-0547", "doi-asserted-by": "publisher"}, {"key": "p_29", "author": "Baeuerle PA", "volume": "11", "first-page": "22", "year": "2009", "journal-title": "Curr Opin Mol Ther"}, {"key": "p_30", "DOI": "10.1002/ijc.20908", "doi-asserted-by": "publisher"}, {"key": "p_31", "DOI": "10.1016/j.molimm.2005.03.007", "doi-asserted-by": "publisher"}, {"key": "p_32", "DOI": "10.1097/CJI.0b013e318156750c", "doi-asserted-by": "publisher"}, {"key": "p_33", "DOI": "10.1016/j.imbio.2008.11.014", "doi-asserted-by": "publisher"}, {"key": "p_34", "DOI": "10.1073/pnas.1000976107", "doi-asserted-by": "publisher"}, {"key": "p_35", "DOI": "10.1097/CJI.0b013e31819b7c70", "doi-asserted-by": "publisher"}, {"key": "p_36", "unstructured": "Kischel R, Hausmann S, Klinger M, Effector memory T cells make a major contribution to redirected Iysis by T cell-engaging BiTE antibody MT110. 100th Meeting of the American Association for Cancer Research, 2009;abstract#3252."}, {"key": "p_37", "DOI": "10.1007/s00262-007-0298-z", "doi-asserted-by": "publisher"}, {"key": "p_38", "DOI": "10.1038/ni1058", "doi-asserted-by": "publisher"}, {"key": "p_39", "DOI": "10.1126/science.1158545", "doi-asserted-by": "publisher"}, {"key": "p_40", "unstructured": "Viardot A, Goebeler M, Scheele J, Treatment of patients with NHL with CD19/CD3 bispecific antibody blinatumomab (MT103): Double-step dose increase to continuous infusion of 60 \u00b5g/m\u00b2/day is tolerable and highly effective. Annual Meeting of the American Society fo Hematology (ASH) 2010;abstract#2880."}, {"key": "p_41", "unstructured": "Bargou R, Zugmaier G, Goekbuget N, Prolonged leukemia free survival following blinatumomab (anti-CD19 BiTE) treatment of patients with minimal residual disease (MRD) of B precursor ALL: updated results of a phase II study. Annual Meeting of the European Hematology Association, Barcelona, 2010;abstract#598."}, {"key": "p_42", "author": "Handgretinger R", "year": "2010", "volume-title": "Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute Iymphoblastic leukemia. Leukemia"}, {"key": "p_43", "DOI": "10.1159/000046554", "doi-asserted-by": "publisher"}, {"key": "p_44", "DOI": "10.1158/1078-0432.CCR-05-2005", "doi-asserted-by": "publisher"}, {"key": "p_45", "DOI": "10.1007/s12033-010-9250-0", "doi-asserted-by": "publisher"}, {"key": "p_47", "DOI": "10.1056/NEJMoa063842", "doi-asserted-by": "publisher"}, {"key": "p_48", "DOI": "10.1016/0024-3205(95)02045-K", "doi-asserted-by": "publisher"}, {"key": "p_49", "DOI": "10.1097/CJI.0b013e3181a1c097", "doi-asserted-by": "publisher"}, {"key": "p_51", "DOI": "10.1158/0008-5472.CAN-09-0654", "doi-asserted-by": "publisher"}, {"key": "p_52", "author": "Baeuerle PA", "volume-title": "Clinical experience with gene therapy and bispecific antibodies for T cell-based therapy of cancer. Curr Pharm Biotechnol 2011"}], "container-title": ["Cancer Vaccines"], "link": [{"URL": "http://www.crcnetbase.com/doi/pdf/10.3109/9781841848303-19", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 21]], "date-time": "2017-06-21T08:43:52Z", "timestamp": 1498034632000}, "score": 51.147663, "issued": {"date-parts": [[2011, 8, 23]]}, "ISBN": ["9781841848297", "9781841848303"], "references-count": 50, "alternative-id": ["10.3109/9781841848303-19", "10.3109/9781841848303"], "URL": "http://dx.doi.org/10.3109/9781841848303-19", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T17:22:31Z", "timestamp": 1574529751946}, "edition-number": "First", "reference-count": 45, "publisher": "Informa Healthcare", "isbn-type": [{"value": "1841848301", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011, 8]]}, "DOI": "10.3109/9781841848303.018", "type": "book-chapter", "created": {"date-parts": [[2011, 7, 26]], "date-time": "2011-07-26T09:29:27Z", "timestamp": 1311672567000}, "page": "250-262", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Passive immunotherapy by T cell\u2013engaging bispecific antibodies"], "prefix": "10.3109", "author": [{"given": "Patrick A.", "family": "Baeuerle", "sequence": "first", "affiliation": []}, {"given": "Benno", "family": "Rattel", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2011, 7, 26]]}, "reference": [{"key": "p_1", "DOI": "10.1126/science.8171337", "doi-asserted-by": "publisher"}, {"key": "p_2", "author": "Altenschmidt U", "volume": "159", "first-page": "5509", "year": "1997", "journal-title": "J Immunol"}, {"key": "p_3", "DOI": "10.1016/j.molimm.2005.07.034", "doi-asserted-by": "publisher"}, {"key": "p_4", "DOI": "10.1073/pnas.0813101106", "doi-asserted-by": "publisher"}, {"key": "p_5", "author": "Weber J.", "volume": "58", "first-page": "823", "year": "2009", "journal-title": "Cancer Immunol Immunother", "DOI": "10.1007/s00262-008-0653-8", "doi-asserted-by": "crossref"}, {"key": "p_6", "DOI": "10.1056/NEJMoa020177", "doi-asserted-by": "publisher"}, {"key": "p_7", "DOI": "10.1056/NEJMoa051424", "doi-asserted-by": "publisher"}, {"key": "p_8", "DOI": "10.1158/1078-0432.CCR-06-1734", "doi-asserted-by": "publisher"}, {"key": "p_9", "DOI": "10.1146/annurev.immunol.25.022106.141609", "doi-asserted-by": "publisher"}, {"key": "p_10", "DOI": "10.1038/314628a0", "doi-asserted-by": "publisher"}, {"key": "p_11", "author": "M\u00fcller D", "volume": "9", "first-page": "319", "year": "2007", "journal-title": "Curr Opin Mol Ther"}, {"key": "p_12", "author": "Seimetz D", "volume": "36", "first-page": "458", "year": "2010", "journal-title": "Cancer Treat Rev", "DOI": "10.1016/j.ctrv.2010.03.001", "doi-asserted-by": "crossref"}, {"key": "p_13", "author": "Ruf P", "volume": "69", "first-page": "617", "year": "2010", "journal-title": "Br J Pharmacol", "DOI": "10.1111/j.1365-2125.2010.03635.x", "doi-asserted-by": "crossref"}, {"key": "p_14", "author": "Lindhofer H", "volume": "155", "first-page": "219", "year": "1995", "journal-title": "J Immunol"}, {"key": "p_15", "DOI": "10.1007/s00262-010-0894-1", "doi-asserted-by": "publisher"}, {"key": "p_16", "DOI": "10.1007/s00262-007-0310-7", "doi-asserted-by": "publisher"}, {"key": "p_17", "author": "Fiedler WM", "volume": "28", "first-page": "2573", "year": "2010", "journal-title": "J Clin Oncol", "DOI": "10.1200/jco.2010.28.15_suppl.2573", "doi-asserted-by": "crossref"}, {"key": "p_18", "author": "Kiewe P", "volume": "12", "first-page": "3085", "year": "2008", "journal-title": "Clin Cancer Res", "DOI": "10.1158/1078-0432.CCR-05-2436", "doi-asserted-by": "crossref"}, {"key": "p_19", "author": "Buhmann R", "volume": "48", "first-page": "383", "year": "2009", "journal-title": "Bone Marrow Transplant", "DOI": "10.1038/bmt.2008.323", "doi-asserted-by": "crossref"}, {"key": "p_20", "author": "Str\u00f6hlein MA", "volume": "14", "first-page": "18", "year": "2009", "journal-title": "J Exp Clin Cancer Res", "DOI": "10.1186/1756-9966-28-18", "doi-asserted-by": "crossref"}, {"key": "p_21", "DOI": "10.1016/S1473-3099(02)00222-0", "doi-asserted-by": "publisher"}, {"key": "p_22", "DOI": "10.1517/14712590903575620", "doi-asserted-by": "publisher"}, {"key": "p_23", "DOI": "10.1054/bjoc.2001.1891", "doi-asserted-by": "publisher"}, {"key": "p_24", "DOI": "10.1200/JCO.2004.12.034", "doi-asserted-by": "publisher"}, {"key": "p_25", "DOI": "10.1200/JCO.2008.20.2515", "doi-asserted-by": "publisher"}, {"key": "p_26", "DOI": "10.1038/sj.bjc.6603567", "doi-asserted-by": "publisher"}, {"key": "p_27", "author": "Forsberg G", "volume": "33", "first-page": "492", "year": "2010", "journal-title": "J Immunother", "DOI": "10.1097/CJI.0b013e3181d75820", "doi-asserted-by": "crossref"}, {"key": "p_28", "DOI": "10.1158/0008-5472.CAN-09-0547", "doi-asserted-by": "publisher"}, {"key": "p_29", "author": "Baeuerle PA", "volume": "11", "first-page": "22", "year": "2009", "journal-title": "Curr Opin Mol Ther"}, {"key": "p_30", "DOI": "10.1002/ijc.20908", "doi-asserted-by": "publisher"}, {"key": "p_31", "DOI": "10.1016/j.molimm.2005.03.007", "doi-asserted-by": "publisher"}, {"key": "p_32", "DOI": "10.1097/CJI.0b013e318156750c", "doi-asserted-by": "publisher"}, {"key": "p_33", "DOI": "10.1016/j.imbio.2008.11.014", "doi-asserted-by": "publisher"}, {"key": "p_34", "author": "Lutterbuese R", "volume": "107", "first-page": "12605", "year": "2010", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.1000976107", "doi-asserted-by": "crossref"}, {"key": "p_35", "DOI": "10.1097/CJI.0b013e31819b7c70", "doi-asserted-by": "publisher"}, {"key": "p_37", "DOI": "10.1007/s00262-007-0298-z", "doi-asserted-by": "publisher"}, {"key": "p_38", "author": "Purbhoo MA", "volume": "5", "first-page": "524", "year": "2004", "journal-title": "Nat Immunol", "DOI": "10.1038/ni1058", "doi-asserted-by": "crossref"}, {"key": "p_39", "DOI": "10.1126/science.1158545", "doi-asserted-by": "publisher"}, {"key": "p_43", "author": "Lum LG", "volume": "105", "first-page": "130", "year": "2010", "journal-title": "Acta Hematol", "DOI": "10.1159/000046554", "doi-asserted-by": "crossref"}, {"key": "p_44", "DOI": "10.1158/1078-0432.CCR-05-2005", "doi-asserted-by": "publisher"}, {"key": "p_45", "author": "Liddy N", "volume": "45", "first-page": "140", "year": "2010", "journal-title": "Mol Biotechnol", "DOI": "10.1007/s12033-010-9250-0", "doi-asserted-by": "crossref"}, {"key": "p_47", "DOI": "10.1056/NEJMoa063842", "doi-asserted-by": "publisher"}, {"key": "p_48", "author": "Blackman MA", "volume": "57", "first-page": "1717", "year": "1995", "journal-title": "Life Sci", "DOI": "10.1016/0024-3205(95)02045-K", "doi-asserted-by": "crossref"}, {"key": "p_49", "DOI": "10.1097/CJI.0b013e3181a1c097", "doi-asserted-by": "publisher"}, {"key": "p_51", "DOI": "10.1158/0008-5472.CAN-09-0654", "doi-asserted-by": "publisher"}], "container-title": ["Cancer Vaccines: From Research to Clinical Practice"], "deposited": {"date-parts": [[2019, 6, 13]], "date-time": "2019-06-13T10:12:45Z", "timestamp": 1560420765000}, "score": 50.029846, "issued": {"date-parts": [[2011, 7, 26]]}, "ISBN": ["1841848301"], "references-count": 45, "alternative-id": ["10.3109/9781841848303.018", "10.3109/9781841848303"], "URL": "http://dx.doi.org/10.3109/9781841848303.018", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T16:41:00Z", "timestamp": 1574527260339}, "publisher-location": "Berlin, Heidelberg", "reference-count": 67, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642209093", "type": "print"}, {"value": "9783642209109", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011]]}, "DOI": "10.1007/978-3-642-20910-9_15", "type": "book-chapter", "created": {"date-parts": [[2011, 7, 19]], "date-time": "2011-07-19T12:53:18Z", "timestamp": 1311079998000}, "page": "273-287", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Bispecific T Cell Engager for Cancer Therapy"], "prefix": "10.1007", "author": [{"given": "Patrick A.", "family": "Baeuerle", "sequence": "first", "affiliation": []}, {"given": "Gerhard", "family": "Zugmaier", "sequence": "additional", "affiliation": []}, {"given": "Dominik", "family": "R\u00fcttinger", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 7, 1]]}, "reference": [{"issue": "4", "key": "15_CR1", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1016/j.cbpa.2010.06.170", "volume": "14", "author": "SC Alley", "year": "2010", "unstructured": "Alley SC, Okeley NM, Senter PD (2010) Antibody-drug conjugates: targeted drug delivery for cancer. Curr Opin Chem Biol 14(4):529\u2013537", "journal-title": "Curr Opin Chem Biol"}, {"issue": "11", "key": "15_CR2", "first-page": "5509", "volume": "159", "author": "U Altenschmidt", "year": "1997", "unstructured": "Altenschmidt U, Klundt E, Groner B (1997) Adoptive transfer of in-vitro-targeted, activated lymphocytes results in total tumor regression. J Immunol 159(11):5509\u20135515", "journal-title": "J Immunol"}, {"issue": "1", "key": "15_CR3", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1158/0008-5472.CAN-07-2182", "volume": "68", "author": "M Amann", "year": "2008", "unstructured": "Amann M, Brischwein K, Lutterbuese P, Parr L, Petersen L, Lorenczewski G, Krinner E, Bruckmeier S, Lippold S, Kischel R, Lutterbuese R, Kufer P, Baeuerle PA, Schlereth B (2008) Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3. Cancer Res 68(1):143\u2013151", "journal-title": "Cancer Res"}, {"issue": "1", "key": "15_CR4", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1007/s00262-008-0529-y", "volume": "58", "author": "M Amann", "year": "2009", "unstructured": "Amann M, Friedrich M, Lutterbuese P, Vieser E, Lorenczewski G, Petersen L, Brischwein K, Kufer P, Kischel R, Baeuerle PA, Schlereth B (2009a) Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans. Cancer Immunol Immunother 58(1):95\u2013109", "journal-title": "Cancer Immunol Immunother"}, {"issue": "5", "key": "15_CR5", "doi-asserted-by": "publisher", "first-page": "452", "DOI": "10.1097/CJI.0b013e3181a1c097", "volume": "32", "author": "M Amann", "year": "2009", "unstructured": "Amann M, D'Argouges S, Lorenczewski G, Brischwein K, Kischel R, Lutterbuese R, Mangold S, Rau D, Volkland J, Pflanz S, Raum T, M\u00fcnz M, Kufer P, Schlereth B, Baeuerle PA, Friedrich M (2009) Antitumor activity of an EpCAM/CD3-bispecific BiTE antibody during long-term treatment of mice in the absence of T-cell anergy and sustained cytokine release. J Immunother 32(5):452\u2013464", "journal-title": "J Immunother"}, {"key": "15_CR67", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1358/dof.2008.033.02.1172578", "volume": "33", "author": "PA Baeuerle", "year": "2008", "unstructured": "Baeuerle PA, Reinhardt C, Kufer P (2008) BiTE \u2013 a new class of antibodies that recruit T cells. Drugs of the Future 33:137\u2013147", "journal-title": "Drugs of the Future"}, {"issue": "12", "key": "15_CR6", "doi-asserted-by": "publisher", "first-page": "4941", "DOI": "10.1158/0008-5472.CAN-09-0547", "volume": "69", "author": "PA Baeuerle", "year": "2009", "unstructured": "Baeuerle PA, Reinhardt C (2009) Bispecific T cell engaging antibodies for cancer therapy. Cancer Res 69(12):4941\u20134944", "journal-title": "Cancer Res"}, {"issue": "1", "key": "15_CR7", "first-page": "22", "volume": "11", "author": "PA Baeuerle", "year": "2009", "unstructured": "Baeuerle PA, Kufer P, Bargou R (2009) BiTE: teaching antibodies to engage T cells. Curr Opin Mol Ther 11(1):22\u201330", "journal-title": "Curr Opin Mol Ther"}, {"issue": "3", "key": "15_CR8", "doi-asserted-by": "publisher", "first-page": "403", "DOI": "10.1016/j.beha.2010.07.001", "volume": "23", "author": "ED Ball", "year": "2010", "unstructured": "Ball ED, Broome HE (2010) Monoclonal antibodies in the treatment of hemtologic malignancy. Best Pract Res Clin Haematol 23(3):403\u2013416", "journal-title": "Best Pract Res Clin Haematol"}, {"issue": "5891", "key": "15_CR9", "doi-asserted-by": "publisher", "first-page": "974", "DOI": "10.1126/science.1158545", "volume": "321", "author": "R Bargou", "year": "2008", "unstructured": "Bargou R, Leo E, Zugmaier G, Goebeler M, Knop S, Noppeney R, Viardot A, Hess G, Schuler M, Einsele H, Riethm\u00fcller G, Brandl C, Wolf A, Kirchinger P, Klappers P, Schmidt M, Klinger M, Reinhardt C, Baeuerle PA, Kufer P (2008) Tumor regression in cancer patients by very low doses of a T cell-engaging antibody. Science 321(5891):974\u2013977", "journal-title": "Science"}, {"key": "15_CR10", "unstructured": "Bargou R, Zugmaier G, Goekbuget N, Neumann S, Horst H-A, Raff T, Brueggemann M, Kneba M, Viardot A, Schmid M, Schaich M, Stelljes M, Goebeler M, Pfeifer H, Ottmann O, Burmeister T, Degenhard E, Schmidt M, Scheele J, Einsele H, Kufer P, Klinger M, Nagorsen D, Hoelzer D, Topp M (2010) Prolonged leukemia free survival following blinatumomab (anti-CD19 BiTE) treatment of patients with minimal residual disease (MRD) of B precursor ALL: updated results of a phase II study. Annual meeting of the European Hematology Association, Barcelona 2010, abstract no 598"}, {"issue": "8", "key": "15_CR11", "doi-asserted-by": "publisher", "first-page": "1197", "DOI": "10.1007/s00262-010-0844-y", "volume": "59", "author": "C Bluemel", "year": "2010", "unstructured": "Bluemel C, Hausmann S, Fluhr P, Sriskandarajah M, Stallcup WB, Baeuerle PA, Kufer P (2010) Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen. Cancer Immunol Immunother 59(8):1197\u20131209", "journal-title": "Cancer Immunol Immunother"}, {"issue": "10", "key": "15_CR12", "doi-asserted-by": "publisher", "first-page": "1551", "DOI": "10.1007/s00262-007-0298-z", "volume": "56", "author": "C Brandl", "year": "2007", "unstructured": "Brandl C, Haas C, d' Argouges S, Fisch T, Kufer P, Brischwein K, Prang N, Bargou R, Suzich J, Baeuerle PA, Hofmeister R (2007) The effect of dexamethasone on polyclonal T cell activation and redirected target cell lysis as induced by a CD19/CD3-bispecific single-chain antibody construct. Cancer Immunol Immunother 56(10):1551\u20131563", "journal-title": "Cancer Immunol Immunother"}, {"issue": "8", "key": "15_CR13", "doi-asserted-by": "publisher", "first-page": "1129", "DOI": "10.1016/j.molimm.2005.07.034", "volume": "43", "author": "K Brischwein", "year": "2006", "unstructured": "Brischwein K, Schlereth B, Guller B, Steiger C, Wolf A, Lutterbuese R, Offner S, Locher M, Urbig T, Raum T, Kleindienst P, Kimmig R, Fichtner I, Kufer P, da Silva AJ, Baeuerle PA (2006) MT110: a novel bispecific single-chain antibody construct with high efficacy in eradicating solid tumors. Mol Immunol 43(8):1129\u20131143", "journal-title": "Mol Immunol"}, {"issue": "8", "key": "15_CR15", "doi-asserted-by": "publisher", "first-page": "798", "DOI": "10.1097/CJI.0b013e318156750c", "volume": "30", "author": "K Brischwein", "year": "2007", "unstructured": "Brischwein K, Parr L, Pflanz S, Volkland J, Lumsden J, Klinger M, Locher M, Hammond SA, Kiener P, Kufer P, Schlereth B, Baeuerle PA (2007) Strictly target cell-dependent activation of T cells by bispecific single-chain antibody constructs of the BiTE class. J Immunother 30(8):798\u2013807", "journal-title": "J Immunother"}, {"issue": "9", "key": "15_CR17", "doi-asserted-by": "publisher", "first-page": "3360", "DOI": "10.1073/pnas.0813101106", "volume": "106", "author": "C Carpenito", "year": "2009", "unstructured": "Carpenito C, Milone MC, Hassan R, Simonet JC, Lakhal M, Suhoski MM, Varela-Rohena A, Haines KM, Heitjan KM, Albelda SM, Carroll RG, Riley JL, Pastan I, June CH (2009) Control of large, established tumor xenografts with genetically engineered human T cells containing CD28 and CD137 domains. Proc Natl Acad Sci USA 106(9):3360\u20133365", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "4", "key": "15_CR18", "doi-asserted-by": "publisher", "first-page": "252", "DOI": "10.1016/j.autrev.2005.07.004", "volume": "5", "author": "G Denkberg", "year": "2006", "unstructured": "Denkberg G, Reiter Y (2006) Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I penetration. Autoimmun Rev 5(4):252\u2013257", "journal-title": "Autoimmun Rev"}, {"issue": "6", "key": "15_CR19", "doi-asserted-by": "publisher", "first-page": "690", "DOI": "10.1002/ijc.10557", "volume": "100", "author": "T Dreier", "year": "2002", "unstructured": "Dreier T, Lorenczewski G, Brandl C, Hoffmann P, Syring U, Hanakam F, Kufer P, Riethmuller G, Bargou R, Baeuerle PA (2002) Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody. Int J Cancer 100(6):690\u2013697", "journal-title": "Int J Cancer"}, {"issue": "8", "key": "15_CR20", "doi-asserted-by": "crossref", "first-page": "4397", "DOI": "10.4049/jimmunol.170.8.4397", "volume": "170", "author": "T Dreier", "year": "2003", "unstructured": "Dreier T, Baeuerle PA, Fichtner I, Gr\u00fcn M, Schlereth B, Lorenczewski G, Kufer P, Lutterb\u00fcse R, Riethm\u00fcller G, Gjorstrup P, Bargou RC (2003) T cell costimulus-independent and very efficacious inhibition of tumor growth in mice bearing subcutaneous or leukemic human B cell lymphoma xenografts by a CD19-/CD3-bispecific single-chain antibody construct. J Immunol 170(8):4397\u20134402", "journal-title": "J Immunol"}, {"key": "15_CR21", "doi-asserted-by": "crossref", "first-page": "15s", "DOI": "10.1200/jco.2010.28.15_suppl.2573", "volume": "28", "author": "WM Fiedler", "year": "2010", "unstructured": "Fiedler WM, Ritter B, Seggewiss R, Bokemeyer C, Fettes P, Klinger M, Vieser E, Ruettinger D, Kaubitzsch S, Wolf M (2010) Phase I safety and pharmacology study of the EpCAM/CD3-bispecific BiTE antibody MT110 in patients with metastatic colorectal, gastric, or lung cancer. J Clin Oncol 28:15s, abstract no 2573", "journal-title": "J Clin Oncol"}, {"key": "15_CR22", "unstructured": "Goebeler M, Viardot A, Knop S, Topp M, S\u00f6keler M, Kanz L, Krause S, Mackensen A, Noppeney R, Nagorsen D, Zugmaier G, Klinger M, Schmidt M, Scheele J, Klappers P, Kufer P, Einsele H, Bargou R (2010) Confirmation of safety, efficacy and response duration in non-Hodgkin lymphoma patients treated with 60\u00a0\u03bcg/m\u00b2/d of BiTE antibody blinatumomab. Annual meeting of the European Hematology Association, Barcelona 2010, abstract no 559"}, {"issue": "6", "key": "15_CR23", "doi-asserted-by": "publisher", "first-page": "441", "DOI": "10.1016/j.imbio.2008.11.014", "volume": "214", "author": "C Haas", "year": "2009", "unstructured": "Haas C, Krinner E, Brischwein K, Hoffmann P, Lutterb\u00fcse R, Schlereth B, Kufer P, Baeuerle PA (2009) Mode of cytotoxic action of T cell-engaging BiTE antibody MT110. Immunobiology 214(6):441\u2013453", "journal-title": "Immunobiology"}, {"issue": "8", "key": "15_CR24", "doi-asserted-by": "publisher", "first-page": "3927", "DOI": "10.1158/0008-5472.CAN-06-2760", "volume": "67", "author": "SA Hammond", "year": "2007", "unstructured": "Hammond SA, Lutterbuese R, Roff S, Lutterbuese P, Schlereth B, Bruckheimer E, Kinch MS, Coats S, Baeuerle PA, Kufer P, Kiener PA (2007) Selective targeting and potent control of tumor growth using an EphA2/CD3-bispecific single-chain antibody construct. Cancer Res 67(8):3927\u20133935", "journal-title": "Cancer Res"}, {"issue": "1", "key": "15_CR25", "doi-asserted-by": "publisher", "first-page": "98", "DOI": "10.1002/ijc.20908", "volume": "115", "author": "P Hoffmann", "year": "2005", "unstructured": "Hoffmann P, Hofmeister R, Brischwein K, Brandl C, Crommer S, Bargou R, Itin C, Prang N, Baeuerle PA (2005) Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct. Int J Cancer 115(1):98\u2013104", "journal-title": "Int J Cancer"}, {"key": "15_CR68", "unstructured": "Kischel R, Raum T, Hausmann S, Rau D, Bluemel C, Mangold S, Meier P, Ebert E, Kvesic M, Hoffman P, Baeuerle PA, Kufer P (2008) Characterization in primates of MCSP- and CD33-specific human BiTE antibodies for treatment of melanoma and AML. Proc Am Assoc Cancer Res 99: Abstract no 2404"}, {"key": "15_CR26", "unstructured": "Kischel R, Hausmann S, Klinger M, Baeuerle PA, Kufer P (2009) Effector memory T cells make a major contribution to redirected lysis by T cell-engaging BiTE antibody MT110. 100th meeting of the American Association for Cancer Research 2009, abstract no 3252"}, {"issue": "9", "key": "15_CR27", "doi-asserted-by": "publisher", "first-page": "1566", "DOI": "10.1111/j.1349-7006.2009.01222.x", "volume": "100", "author": "T Kubota", "year": "2009", "unstructured": "Kubota T, Niwa R, Satoh M, Akinaga S, Shitara K, hanai N (2009) Engineered therapeutic antibodies with improved effector functions. Cancer Sci 100(9):1566\u20131572", "journal-title": "Cancer Sci"}, {"key": "15_CR69", "doi-asserted-by": "crossref", "first-page": "238", "DOI": "10.1016/j.tibtech.2004.03.006", "volume": "22", "author": "P Kufer", "year": "2004", "unstructured": "Kufer P, Lutterbuese R, Baeuerle PA (2004) A revival of bispecific antibodies. Trends Biotechnol 22:238\u2013244", "journal-title": "Trends Biotechnol"}, {"issue": "1", "key": "15_CR28", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1111/j.0105-2896.2010.00894.x", "volume": "235", "author": "FC Kurschus", "year": "2010", "unstructured": "Kurschus FC, Jenne D (2010) Delivery and therapeutic potential of human granzyme B. Immunol Rev 235(1):159\u2013171", "journal-title": "Immunol Rev"}, {"issue": "37", "key": "15_CR29", "doi-asserted-by": "publisher", "first-page": "13799", "DOI": "10.1073/pnas.0801724105", "volume": "105", "author": "FC Kurschus", "year": "2008", "unstructured": "Kurschus FC, Fellows E, Stegmann E, Jenne DE (2008) Granzyme B delivery via perforin is restricted by size, but not by heparan sulfate-dependent endocytosis. Proc Natl Acad Sci USA 105(37):13799\u201313804", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "2", "key": "15_CR30", "doi-asserted-by": "publisher", "first-page": "462", "DOI": "10.1053/gast.1996.v111.pm8690213", "volume": "111", "author": "S K\u00fcsters", "year": "1996", "unstructured": "K\u00fcsters S, Gantner F, K\u00fcnstle G, Tiegs G (1996) Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111(2):462\u2013471", "journal-title": "Gastroenterology"}, {"issue": "11", "key": "15_CR31", "doi-asserted-by": "publisher", "first-page": "2870", "DOI": "10.1002/eji.1830271119", "volume": "27", "author": "S K\u00fcsters", "year": "1997", "unstructured": "K\u00fcsters S, Tiegs G, Alexopoulo L, Pasparakis M, Douni E, K\u00fcnstle G, Bluethmann H, Wendel A, Pfizenmaier K, Kollias G, Grell M (1997) In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol 27(11):2870\u20132905", "journal-title": "Eur J Immunol"}, {"issue": "2", "key": "15_CR32", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.4161/mabs.2.2.11221", "volume": "2", "author": "R Linke", "year": "2010", "unstructured": "Linke R, Klein A, Seimetz D (2010) Catumaxomab: clinical development and future directions. MAbs 2(2):129\u2013136", "journal-title": "MAbs"}, {"issue": "5", "key": "15_CR33", "doi-asserted-by": "publisher", "first-page": "900", "DOI": "10.1038/sj.leu.2402890", "volume": "17", "author": "A L\u00f6ffler", "year": "2003", "unstructured": "L\u00f6ffler A, Gruen M, Wuchter C, Schriever F, Kufer P, Dreier T, Hanakam F, Baeuerle PA, Bommert K, Karawajew L, D\u00f6rken B, Bargou RC (2003) Efficient elimination of chronic lymphocytic leukaemia B cells by autologous T cells with a bispecific anti-CD19/anti-CD3 single-chain antibody construct. Leukemia 17(5):900\u2013909", "journal-title": "Leukemia"}, {"issue": "1", "key": "15_CR34", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/j.exphem.2005.07.013", "volume": "34", "author": "LG Lum", "year": "2006", "unstructured": "Lum LG, Davol PA, Lee RJ (2006) The new face of bispecific antibodies: targeting cancer and much more. Exp Hematol 34(1):1\u20136", "journal-title": "Exp Hematol"}, {"issue": "4", "key": "15_CR35", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1097/CJI.0b013e31819b7c70", "volume": "32", "author": "R Lutterbuese", "year": "2009", "unstructured": "Lutterbuese R, Raum T, Kischel R, Lutterbuese P, Schlereth B, Schaller E, Mangold S, Rau D, Meier P, Kiener PA, Mulgrew K, Oberst MD, Hammond SA, Baeuerle PA, Kufer P (2009) Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA. J Immunother 32(4):341\u2013352", "journal-title": "J Immunother"}, {"issue": "28", "key": "15_CR36", "doi-asserted-by": "publisher", "first-page": "12605", "DOI": "10.1073/pnas.1000976107", "volume": "107", "author": "R Lutterbuese", "year": "2010", "unstructured": "Lutterbuese R, Raum T, Kischel R, Hoffmann P, Mangold S, Rattel B, Friedrich M, Thomas O, Lorenczewski G, Rau D, Schaller E, Herrmann I, Wolf A, Urbig T, Baeuerle PA, Kufer P (2010) T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells. Proc Natl Acad Sci USA 107(28):12605\u201312610", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "2", "key": "15_CR37", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1016/j.tibs.2007.10.008", "volume": "33", "author": "S Minguet", "year": "2008", "unstructured": "Minguet S, Schamel WW (2008) A permissive geometry model for TCR-CD3 activation. Trends Biochem Sci 33(2):51\u201357", "journal-title": "Trends Biochem Sci"}, {"issue": "8", "key": "15_CR38", "doi-asserted-by": "publisher", "first-page": "1945", "DOI": "10.1016/j.molimm.2006.09.032", "volume": "44", "author": "M Molhoj", "year": "2007", "unstructured": "Molhoj M, Crommer S, Rau D, Sriskandarajah M, Kufer P, Brischwein K, Hofmeister R, Baeuerle PA (2007) CD19/CD3-bispecific antibody of the BiTE class is far superior to tandem diabody with respect to redirected tumor cell lysis. Mol Immunol 44(8):1945\u20131953", "journal-title": "Mol Immunol"}, {"key": "15_CR39", "unstructured": "Moore PA, Zhang W, Rainey J, Burke S, Huang L, Li H, Veri C, Yang Y, He L, Ciccarone V, Gorlatov S, Aggarwal S, Alderson R, Koenig S, Bonvini E, Johnson S (2010) Application of a novel bispecific antibody-based scaffold for optimal redirected T-cell killing of cancer cells. 101st Annual meeting of the American Association for Cancer Research 2010, abstract no 5629"}, {"key": "15_CR40", "first-page": "11", "volume": "12", "author": "MA Morse", "year": "2010", "unstructured": "Morse MA, Whelan M (2010) A year of successful cancer vaccines points to a path forward. Curr Opin Mol Ther 12:11\u201313", "journal-title": "Curr Opin Mol Ther"}, {"issue": "4", "key": "15_CR41", "first-page": "319", "volume": "9", "author": "D M\u00fcller", "year": "2007", "unstructured": "M\u00fcller D, Kontermann RE (2007) Recombinant bispecific antibodies for cellular cancer immunotherapy. Curr Opin Mol Ther 9(4):319\u2013326", "journal-title": "Curr Opin Mol Ther"}, {"issue": "2", "key": "15_CR42", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.2165/11530960-000000000-00000", "volume": "24", "author": "D M\u00fcller", "year": "2010", "unstructured": "M\u00fcller D, Kontermann RE (2010) Bispecific antibodies for cancer immunotherapy: current perspectives. BioDrugs 24(2):89\u201398", "journal-title": "BioDrugs"}, {"issue": "14", "key": "15_CR43", "doi-asserted-by": "publisher", "first-page": "5627", "DOI": "10.1158/0008-5472.CAN-09-0654", "volume": "69", "author": "M Munz", "year": "2009", "unstructured": "Munz M, Baeuerle PA, Gires O (2009) The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res 69(14):5627\u20135629", "journal-title": "Cancer Res"}, {"issue": "6", "key": "15_CR44", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1080/10428190902943077", "volume": "50", "author": "D Nagorsen", "year": "2009", "unstructured": "Nagorsen D, Bargou R, Ruettinger D, Kufer P, Baeuerle PA, Zugmaier G (2009a) Immunotherapy of lymphoma and leukemia with T cell-engaging BiTE antibody blinatumomab. Leuk Lymphoma 50(6):1\u20136", "journal-title": "Leuk Lymphoma"}, {"key": "15_CR45", "first-page": "4793", "volume": "114", "author": "D Nagorsen", "year": "2009", "unstructured": "Nagorsen D, Zugmaier G, Viardot A, Goebeler M, Noppeney R, Schmidt M, Klappers P, Baeuerle PA, Kufer P, Bargou RC (2009) Confirmation of safety, efficacy and response duration in non-Hodgkin lymphoma patients treated with 60\u00a0\u03bcg/m2/d of BiTE\u00ae antibody blinatumomab. Blood 114:4793 (ASH Annual Meeting Abstracts)", "journal-title": "Blood"}, {"issue": "6", "key": "15_CR46", "doi-asserted-by": "publisher", "first-page": "763", "DOI": "10.1016/j.molimm.2005.03.007", "volume": "43", "author": "S Offner", "year": "2006", "unstructured": "Offner S, Hofmeister R, Romaniuk A, Kufer P, Baeuerle PA (2006) Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells. Mol Immunol 43(6):763\u2013771", "journal-title": "Mol Immunol"}, {"issue": "1", "key": "15_CR47", "doi-asserted-by": "publisher", "first-page": "124", "DOI": "10.1038/sj.bjc.6605364", "volume": "102", "author": "T Osada", "year": "2010", "unstructured": "Osada T, Hsu D, Hammond S, Hobeika A, Devi G, Clay TM, Lyerly HK, Morse MA (2010) Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody. Br J Cancer 102(1):124\u2013133", "journal-title": "Br J Cancer"}, {"issue": "25", "key": "15_CR48", "doi-asserted-by": "publisher", "first-page": "2654", "DOI": "10.1056/NEJMoa051424", "volume": "353", "author": "F Pag\u00e8s", "year": "2005", "unstructured": "Pag\u00e8s F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353(25):2654\u20132666", "journal-title": "N Engl J Med"}, {"issue": "5", "key": "15_CR49", "doi-asserted-by": "publisher", "first-page": "524", "DOI": "10.1038/ni1058", "volume": "5", "author": "MA Purbhoo", "year": "2004", "unstructured": "Purbhoo MA, Irvine DJ, Huppa JB, Davis MM (2004) T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol 5(5):524\u2013530", "journal-title": "Nat Immunol"}, {"key": "15_CR50", "doi-asserted-by": "publisher", "first-page": "267", "DOI": "10.1146/annurev.immunol.25.022106.141609", "volume": "25", "author": "GA Rabinovich", "year": "2007", "unstructured": "Rabinovich GA, Gabrilovich D, Sotomayor EM (2007) Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 25:267\u2013296", "journal-title": "Annu Rev Immunol"}, {"key": "15_CR51", "unstructured": "Raum R, Rau D, Kischel R, Bluemel C, Hausmann S, Steiger C, Meier P, Ebert E, Mangold S, Hoffmann P, Strasser S, Cierpka R, Kvesic M, Baeuerle PA (2010) Novel primate-crossreactive BiTE antibodies that eliminate cancer cells expressing cMet, IGFR-1, FAP-alpha, PSCA, Endosialin, CAIX or Her2/neu. 101st Annual meeting of the American Association for Cancer Research 2010, abstract no 2434"}, {"issue": "5160", "key": "15_CR52", "doi-asserted-by": "publisher", "first-page": "833", "DOI": "10.1126/science.8171337", "volume": "264", "author": "C Renner", "year": "1994", "unstructured": "Renner C, Jung W, Sahin U, Denfeld R, Pohl C, Tr\u00fcmper L, Hartmann F, Diehl V, van Lier R, Pfreundschuh M (1994) Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells. Science 264(5160):833\u2013835", "journal-title": "Science"}, {"issue": "3", "key": "15_CR53", "doi-asserted-by": "publisher", "first-page": "509", "DOI": "10.1002/ijc.20417", "volume": "112", "author": "U Reusch", "year": "2004", "unstructured": "Reusch U, Le Gall F, Hensel M, Moldenhauer G, Ho AD, Little M, Kipriyanov SM (2004) Effect of tetravalent bispecific CD19\u2009\u00d7\u2009CD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells. Int J Cancer 112(3):509\u2013518", "journal-title": "Int J Cancer"}, {"issue": "2", "key": "15_CR54", "doi-asserted-by": "publisher", "first-page": "273", "DOI": "10.1517/14712590903575620", "volume": "10", "author": "MK Robinson", "year": "2010", "unstructured": "Robinson MK, Alpaugh RK, Borghaei H (2010) Naptumomab estafenatox: a new immunoconjugate. Expert Opin Biol Ther 10(2):273\u2013279", "journal-title": "Expert Opin Biol Ther"}, {"key": "15_CR55", "unstructured": "Roman K, Raum T, Hausmann S, Rau D, Bluemel C, Mangold S, Meier P, Ebert E, Kvesic M, Hoffman P, Baeuerle PA, Kufer P (2008) Characterization of novel CD33- and MCSP-specific BiTE antibodies for the treatment of acute myeloid leukemia and melanoma, respectively, that are fully human in sequence. 99th meeting of the American Association for Cancer Research 2008, abstract no 2404"}, {"issue": "4", "key": "15_CR56", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1038/nrc2355", "volume": "8", "author": "SA Rosenberg", "year": "2008", "unstructured": "Rosenberg SA, Restifo N, Yang JC, Morgan RA, Dudley ME (2008) Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8(4):299\u2013308", "journal-title": "Nat Rev Cancer"}, {"issue": "7", "key": "15_CR57", "doi-asserted-by": "publisher", "first-page": "2882", "DOI": "10.1158/0008-5472.CAN-04-2637", "volume": "65", "author": "B Schlereth", "year": "2005", "unstructured": "Schlereth B, Fichtner I, Lorenczewski G, Kleindienst P, Brischwein K, Kufer P, Lutterb\u00fcse R, Wimberger P, Kimmig R, Baeuerle PA (2005) Eradication of tumors from a human colon cancer cell line and primary ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct. Cancer Res 65(7):2882\u20132889", "journal-title": "Cancer Res"}, {"issue": "3", "key": "15_CR58", "first-page": "273", "volume": "10", "author": "J Shen", "year": "2008", "unstructured": "Shen J, Zhu Z (2008) Catumaxomab a rat/murine hybrid trifunctional bispecific monoclonal antibody for the treatment of cancer. Curr Opin Mol Ther 10(3):273\u2013284", "journal-title": "Curr Opin Mol Ther"}, {"issue": "38", "key": "15_CR59", "doi-asserted-by": "publisher", "first-page": "25612", "DOI": "10.1074/jbc.M109.027078", "volume": "284", "author": "R Stork", "year": "2009", "unstructured": "Stork R, Campigna A, Robert B, M\u00fcller D, Kontermann RE (2009) Biodistribution of a bispecific single-chain diabody and its half-life extended derivatives. J Biol Chem 284(38):25612\u201325619", "journal-title": "J Biol Chem"}, {"key": "15_CR60", "first-page": "840", "volume": "114", "author": "MS Topp", "year": "2009", "unstructured": "Topp MS, Zugmaier G, Goekbuet N, Kufer P, Goebeler M, Klinger M, Degenhard E, Baeuerle PA, Schmidt M, Nagorsen D, Neumann S, Horst HA, Raff T, Viardot A, Stelljes M, Schmid M, Ottmann OG, Burmeister T, Einsele H, Riethmueller G, Hoelzer D, Bargou RC (2009) Report of a phase II trial of single-agent BiTE antibody blinatumomab in patients with minimal residual disease (MRD) positive B-precursor acute lymphocytic leukemia (ALL). Blood 114:840 (ASH Annual Meeting Abstract)", "journal-title": "Blood"}, {"issue": "2", "key": "15_CR61", "doi-asserted-by": "publisher", "first-page": "388", "DOI": "10.1158/1078-0432.CCR-06-1734", "volume": "13", "author": "BE Wahlin", "year": "2007", "unstructured": "Wahlin BE, Sander B, Christensson B, Kimby E (2007) CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma. Clin Cancer Res 13(2):388\u2013397", "journal-title": "Clin Cancer Res"}, {"issue": "8", "key": "15_CR62", "doi-asserted-by": "publisher", "first-page": "823", "DOI": "10.1007/s00262-008-0653-8", "volume": "58", "author": "J Weber", "year": "2009", "unstructured": "Weber J (2009) Ipilimumab: controversies in its development, utility and autoimmune adverse events. Cancer Immunol Immunother 58(8):823\u2013830", "journal-title": "Cancer Immunol Immunother"}, {"key": "15_CR63", "doi-asserted-by": "publisher", "first-page": "1059", "DOI": "10.1007/s00262-005-0671-8", "volume": "54", "author": "A Willems", "year": "2005", "unstructured": "Willems A, Schoonooghe S, Eeckhout D, De Jaeger G, Grooten J, Mertens N (2005) CD3\u2009\u00d7\u2009CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activation. Cancer Immunol Immunother 54:1059\u20131071", "journal-title": "Cancer Immunol Immunother"}, {"issue": "2", "key": "15_CR64", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1002/ijc.11056", "volume": "105", "author": "P Wimberger", "year": "2003", "unstructured": "Wimberger P, Xiang W, Mayr D, Diebold J, Dreier T, Baeuerle PA, Kimmig R (2003) Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody. Int J Cancer 105(2):241\u2013248", "journal-title": "Int J Cancer"}, {"issue": "4", "key": "15_CR65", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.4161/mabs.1.4.8755", "volume": "1", "author": "C Wu", "year": "2009", "unstructured": "Wu C, Ying H, Bose S, Miller R, Medina L, Santora L, Ghayur T (2009) Molecular construction and optimization of anti-human IL-1alpha/beta dual variable domain immunoglobulin (DVD-Ig) molecules. MAbs 1(4):339\u2013347", "journal-title": "MAbs"}, {"issue": "3", "key": "15_CR66", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1056/NEJMoa020177", "volume": "348", "author": "L Zhang", "year": "2003", "unstructured": "Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348(3):203\u2013213", "journal-title": "N Engl J Med"}], "container-title": ["Bispecific Antibodies"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-642-20910-9_15", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 30]], "date-time": "2019-03-30T09:16:00Z", "timestamp": 1553937360000}, "score": 48.367126, "issued": {"date-parts": [[2011]]}, "ISBN": ["9783642209093", "9783642209109"], "references-count": 67, "URL": "http://dx.doi.org/10.1007/978-3-642-20910-9_15", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T03:35:08Z", "timestamp": 1574480108413}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CPB"], "published-print": {"date-parts": [[2012, 5, 1]]}, "DOI": "10.2174/138920112800785005", "type": "journal-article", "created": {"date-parts": [[2012, 6, 6]], "date-time": "2012-06-06T12:29:05Z", "timestamp": 1338985745000}, "page": "1399-1408", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Clinical Experience with Gene Therapy and Bispecific Antibodies for T Cell-based Therapy of Cancer"], "prefix": "10.2174", "volume": "13", "author": [{"given": "Patrick", "family": "A. Baeuerle", "sequence": "first", "affiliation": []}, {"given": "Christian", "family": "Itin", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Current Pharmaceutical Biotechnology"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/98852", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2015, 11, 23]], "date-time": "2015-11-23T10:12:55Z", "timestamp": 1448273575000}, "score": 43.070374, "issued": {"date-parts": [[2012, 5, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012, 5, 1]]}, "issue": "8"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/138920112800785005", "ISSN": ["1389-2010"], "issn-type": [{"value": "1389-2010", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T10:11:56Z", "timestamp": 1575281516898}, "publisher-location": "Weinheim, Germany", "reference-count": 39, "publisher": "Wiley-VCH Verlag GmbH & Co. KGaA", "isbn-type": [{"value": "9783527343034", "type": "print"}, {"value": "9783527808694", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9783527808694.ch5", "type": "book-chapter", "created": {"date-parts": [[2018, 4, 17]], "date-time": "2018-04-17T00:00:10Z", "timestamp": 1523923210000}, "page": "111-130", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Development of T-Cell-Engaging Bispecific Antibody Blinatumomab (Blincyto\u00ae) for Treatment of B-Cell Malignancies"], "prefix": "10.1002", "author": [{"given": "Patrick A.", "family": "Baeuerle", "sequence": "first", "affiliation": [{"name": "MPM Capital; 450 Kendall Street Cambridge MA 02142 USA"}, {"name": "Ludwig-Maximilian University; Institute for Immunology; Grosshadenerstr. 9 82152 Planegg-Martinsried Germany"}]}], "member": "311", "published-online": {"date-parts": [[2018, 4, 16]]}, "reference": [{"key": "10.1002/9783527808694.ch5-BIB0001|ch5-cit-0001", "doi-asserted-by": "crossref", "first-page": "4550", "DOI": "10.1158/1078-0432.CCR-11-0116", "article-title": "Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy", "volume": "17", "author": "Rosenberg", "year": "2011", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9783527808694.ch5-BIB0002|ch5-cit-0002", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1053/j.seminoncol.2015.05.013", "article-title": "Antagonists of PD-1 and PD-L1 in cancer treatment", "volume": "42", "author": "Lipson", "year": "2015", "journal-title": "Semin. Oncol."}, {"key": "10.1002/9783527808694.ch5-BIB0003|ch5-cit-0003", "doi-asserted-by": "crossref", "first-page": "3005", "DOI": "10.1073/pnas.0712237105", "article-title": "Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients", "volume": "105", "author": "Hodi", "year": "2008", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "10.1002/9783527808694.ch5-BIB0004|ch5-cit-0004", "first-page": "802", "article-title": "CD19-Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia", "volume": "14", "author": "Davila", "year": "2016", "journal-title": "Clin. Adv. Hematol. Oncol."}, {"key": "10.1002/9783527808694.ch5-BIB0005|ch5-cit-0005", "doi-asserted-by": "crossref", "first-page": "1399", "DOI": "10.2165/11209040-000000000-00000", "article-title": "Catumaxomab: in malignant ascites", "volume": "72", "author": "Frampton", "year": "2012", "journal-title": "Drugs"}, {"key": "10.1002/9783527808694.ch5-BIB0006|ch5-cit-0006", "doi-asserted-by": "crossref", "first-page": "334", "DOI": "10.1016/j.pharmthera.2012.07.013", "article-title": "Blinatumomab: a historical perspective", "volume": "136", "author": "Nagorsen", "year": "2012", "journal-title": "Pharmacol. Ther."}, {"key": "10.1002/9783527808694.ch5-BIB0007|ch5-cit-0007", "doi-asserted-by": "crossref", "first-page": "1453", "DOI": "10.1073/pnas.83.5.1453", "article-title": "Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity", "volume": "83", "author": "Staerz", "year": "1986", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "10.1002/9783527808694.ch5-BIB0008|ch5-cit-0008", "doi-asserted-by": "publisher", "first-page": "368", "DOI": "10.3389/fimmu.2015.00368", "article-title": "NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy", "volume": "27", "author": "Wang", "year": "2015", "journal-title": "Front. Immunol."}, {"key": "10.1002/9783527808694.ch5-BIB0009|ch5-cit-0009", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.4161/mabs.4.2.19000", "article-title": "Dual targeting strategies with bispecific antibodies", "volume": "4", "author": "Kontermann", "year": "2012", "journal-title": "MAbs"}, {"key": "10.1002/9783527808694.ch5-BIB0010|ch5-cit-0010", "doi-asserted-by": "crossref", "first-page": "628", "DOI": "10.1038/314628a0", "article-title": "Hybrid antibodies can target sites for attack by T cells", "volume": "314", "author": "Staerz", "year": "1985", "journal-title": "Nature"}, {"key": "10.1002/9783527808694.ch5-BIB0011|ch5-cit-0011", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1111/j.1600-065X.1995.tb00082.x", "article-title": "Tumour therapy by immune recruitment with bispecific antibodies", "volume": "145", "author": "Renner", "year": "1995", "journal-title": "Immunol. Rev."}, {"key": "10.1002/9783527808694.ch5-BIB0012|ch5-cit-0012", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1016/j.molimm.2015.01.003", "article-title": "Alternative molecular formats and therapeutic applications for bispecific antibodies", "volume": "67", "author": "Spiess", "year": "2015", "journal-title": "Mol. Immunol."}, {"key": "10.1002/9783527808694.ch5-BIB0013|ch5-cit-0013", "doi-asserted-by": "crossref", "first-page": "7021", "DOI": "10.1073/pnas.92.15.7021", "article-title": "A small bispecific antibody construct expressed as a functional single-chain molecule with high tumour cell cytotoxicity", "volume": "92", "author": "Mack", "year": "1995", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "10.1002/9783527808694.ch5-BIB0014|ch5-cit-0014", "doi-asserted-by": "crossref", "first-page": "2098", "DOI": "10.1182/blood.V95.6.2098", "article-title": "A recombinant bispecific single-chain antibody, CD19\u2009\u00d7\u2009CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes", "volume": "95", "author": "Kufer", "year": "2000", "journal-title": "Blood"}, {"key": "10.1002/9783527808694.ch5-BIB0015|ch5-cit-0015", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1089/scd.1.1995.4.433", "article-title": "Clinical experience with CD3\u2009\u00d7\u2009CD19 bispecific antibodies in patients with B cell malignancies", "volume": "4", "author": "De Gast", "year": "1995", "journal-title": "J. Hematother."}, {"key": "10.1002/9783527808694.ch5-BIB0016|ch5-cit-0016", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1002/(SICI)1097-0215(19960516)66:4<477::AID-IJC11>3.0.CO;2-5", "article-title": "Pharmacokinetics, biodistribution and biological effects of intravenously administered bispecific monoclonal antibody OC/TR F(ab\u2032)2 in ovarian carcinoma patients", "volume": "66", "author": "Tibben", "year": "1996", "journal-title": "Int. J. Cancer"}, {"key": "10.1002/9783527808694.ch5-BIB0017|ch5-cit-0017", "doi-asserted-by": "crossref", "first-page": "999", "DOI": "10.3109/10428194.2013.828354", "article-title": "Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond", "volume": "55", "author": "Katz", "year": "2014", "journal-title": "Leuk. Lymphoma"}, {"key": "10.1002/9783527808694.ch5-BIB0018|ch5-cit-0018", "doi-asserted-by": "crossref", "first-page": "798", "DOI": "10.1097/CJI.0b013e318156750c", "article-title": "Strictly target cell-dependent activation of T cells by bispecific single-chain antibody constructs of the BiTE class", "volume": "30", "author": "Brischwein", "year": "2007", "journal-title": "J. Immunother."}, {"key": "10.1002/9783527808694.ch5-BIB0019|ch5-cit-0019", "doi-asserted-by": "crossref", "first-page": "6226", "DOI": "10.1182/blood-2012-01-400515", "article-title": "Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab", "volume": "119", "author": "Klinger", "year": "2012", "journal-title": "Blood"}, {"key": "10.1002/9783527808694.ch5-BIB0020|ch5-cit-0020", "doi-asserted-by": "crossref", "first-page": "763", "DOI": "10.1016/j.molimm.2005.03.007", "article-title": "Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs", "volume": "43", "author": "Offner", "year": "2006", "journal-title": "Mol. Immunol."}, {"issue": "10", "key": "10.1002/9783527808694.ch5-BIB0021|ch5-cit-0021", "doi-asserted-by": "crossref", "first-page": "e0141669", "DOI": "10.1371/journal.pone.0141669", "article-title": "Impact of diverse immune evasion mechanisms of cancer cells on T cells engaged by EpCAM/CD3-bispecific antibody construct AMG 110", "volume": "10", "author": "Deisting", "year": "2015", "journal-title": "PLoS One"}, {"key": "10.1002/9783527808694.ch5-BIB0022|ch5-cit-0022", "doi-asserted-by": "crossref", "first-page": "98", "DOI": "10.1002/ijc.20908", "article-title": "Serial killing of tumour cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct", "volume": "115", "author": "Hoffmann", "year": "2005", "journal-title": "Int. J. Cancer"}, {"key": "10.1002/9783527808694.ch5-BIB0023|ch5-cit-0023", "doi-asserted-by": "crossref", "first-page": "4397", "DOI": "10.4049/jimmunol.170.8.4397", "article-title": "T cell costimulus-independent and very efficacious inhibition of tumour growth in mice bearing subcutaneous or leukemic human B cell lymphoma xenografts by a CD19-/CD3-bispecific single-chain antibody construct", "volume": "170", "author": "Dreier", "year": "2003", "journal-title": "J. Immunol."}, {"key": "10.1002/9783527808694.ch5-BIB0024|ch5-cit-0024", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1007/s00262-005-0001-1", "article-title": "T cell activation and B cell depletion in chimpanzees by an anti-CD19/anti-CD3 single-chain bispecific antibody construct", "volume": "55", "author": "Schlereth", "year": "2006", "journal-title": "Cancer Immunol. Immunother."}, {"key": "10.1002/9783527808694.ch5-BIB0025|ch5-cit-0025", "doi-asserted-by": "crossref", "first-page": "1551", "DOI": "10.1007/s00262-007-0298-z", "article-title": "Dexamethasone does not affect the cytotoxic potential of T cells redirected for tumour cell lysis by a CD19-/CD3-bispecific single-chain antibody construct", "volume": "56", "author": "Brandl", "year": "2007", "journal-title": "Cancer Immunol. Immunother."}, {"key": "10.1002/9783527808694.ch5-BIB0026|ch5-cit-0026", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1016/j.leukres.2008.08.025", "article-title": "Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells", "volume": "33", "author": "d'Argouges", "year": "2009", "journal-title": "Leuk. Res."}, {"key": "10.1002/9783527808694.ch5-BIB0027|ch5-cit-0027", "doi-asserted-by": "crossref", "first-page": "974", "DOI": "10.1126/science.1158545", "article-title": "Tumour regression in cancer patients by very low doses of a T cell-engaging antibody", "volume": "321", "author": "Bargou", "year": "2008", "journal-title": "Science"}, {"key": "10.1002/9783527808694.ch5-BIB0028|ch5-cit-0028", "doi-asserted-by": "crossref", "first-page": "1104", "DOI": "10.1200/JCO.2014.59.1586", "article-title": "Bispecific T-cell engager (BiTE) antibody construct blinatumomab for the treatment of patients with relapsed/refractory non-Hodgkin lymphoma: final results from a phase I study", "volume": "34", "author": "Goebeler", "year": "2016", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527808694.ch5-BIB0029|ch5-cit-0029", "doi-asserted-by": "crossref", "first-page": "2493", "DOI": "10.1200/JCO.2010.32.7270", "article-title": "Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival", "volume": "29", "author": "Topp", "year": "2011", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9783527808694.ch5-BIB0030|ch5-cit-0030", "doi-asserted-by": "crossref", "first-page": "5185", "DOI": "10.1182/blood-2012-07-441030", "article-title": "Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL", "volume": "120", "author": "Topp", "year": "2012", "journal-title": "Blood"}, {"issue": "21", "key": "10.1002/9783527808694.ch5-BIB0031|ch5-cit-0031", "article-title": "BLAST: a confirmatory, single-arm, phase 2 study of blinatumomab, a bispecific T-cell engager (BiTE\u00ae) antibody construct, in patients with minimal residual disease B-precursor acute lymphoblastic leukemia (ALL)", "volume": "124", "author": "Goekbuget", "year": "2014", "journal-title": "Blood"}, {"key": "10.1002/9783527808694.ch5-BIB0032|ch5-cit-0032", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1016/S1470-2045(14)71170-2", "article-title": "Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study", "volume": "16", "author": "Topp", "year": "2015", "journal-title": "Lancet Oncol."}, {"key": "10.1002/9783527808694.ch5-BIB0033|ch5-cit-0033", "doi-asserted-by": "crossref", "first-page": "4595", "DOI": "10.4049/jimmunol.1403014", "article-title": "FcRn: the architect behind the immune and nonimmune functions of IgG and albumin", "volume": "194", "author": "Pyzik", "year": "2015", "journal-title": "J. Immunol."}, {"key": "10.1002/9783527808694.ch5-BIB0034|ch5-cit-0034", "first-page": "677", "article-title": "Prolonged neurological disability following OKT3 therapy for acute renal transplant rejection", "volume": "55", "author": "Jeffrey", "year": "1993", "journal-title": "Transplantation"}, {"key": "10.1002/9783527808694.ch5-BIB0035|ch5-cit-0035", "doi-asserted-by": "crossref", "first-page": "3321", "DOI": "10.1182/blood-2016-04-703751", "article-title": "Toxicities of chimeric antigen receptor T cells: recognition and management", "volume": "127", "author": "Brudno", "year": "2016", "journal-title": "Blood"}, {"key": "10.1002/9783527808694.ch5-BIB0036|ch5-cit-0036", "first-page": "143", "article-title": "Anti-CD19 monoclonal antibodies: a new approach to lymphoma therapy", "volume": "4", "author": "Naddafi", "year": "2015", "journal-title": "Int. J. Mol. Cell. Med."}, {"key": "10.1002/9783527808694.ch5-BIB0037|ch5-cit-0037", "doi-asserted-by": "crossref", "first-page": "180", "DOI": "10.1097/00002281-200405000-00003", "article-title": "B cells as therapeutic targets for rheumatic diseases", "volume": "16", "author": "Looney", "year": "2004", "journal-title": "Curr. Opin. Rheumatol."}, {"key": "10.1002/9783527808694.ch5-BIB0038|ch5-cit-0038", "doi-asserted-by": "crossref", "first-page": "332", "DOI": "10.4103/0975-1483.66810", "article-title": "TGN1412. From discovery to disaster", "volume": "2", "author": "Attarwala", "year": "2010", "journal-title": "J. Young Pharm."}, {"key": "10.1002/9783527808694.ch5-BIB0039|ch5-cit-0039", "doi-asserted-by": "crossref", "first-page": "1079", "DOI": "10.1038/nbt.3349", "article-title": "Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1", "volume": "33", "author": "Dao", "year": "2015", "journal-title": "Nat. Biotechnol."}], "container-title": ["Successful Drug Discovery"], "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F9783527808694.ch5", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/9783527808694.ch5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 16]], "date-time": "2019-10-16T00:38:27Z", "timestamp": 1571186307000}, "score": 41.18077, "issued": {"date-parts": [[2018, 4, 16]]}, "ISBN": ["9783527808694", "9783527343034"], "references-count": 39, "URL": "http://dx.doi.org/10.1002/9783527808694.ch5", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T10:55:50Z", "timestamp": 1574420150486}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2012, 1, 15]]}, "DOI": "10.1158/1078-0432.ccr-11-1270", "type": "journal-article", "created": {"date-parts": [[2011, 11, 18]], "date-time": "2011-11-18T04:28:26Z", "timestamp": 1321590506000}, "page": "465-474", "source": "Crossref", "is-referenced-by-count": 60, "title": ["EpCAM/CD3-Bispecific T-cell Engaging Antibody MT110 Eliminates Primary Human Pancreatic Cancer Stem Cells"], "prefix": "10.1158", "volume": "18", "author": [{"given": "M.", "family": "Cioffi", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Dorado", "sequence": "additional", "affiliation": []}, {"given": "P. A.", "family": "Baeuerle", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Heeschen", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2011, 11, 17]]}, "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-11-1270", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T03:27:37Z", "timestamp": 1482463657000}, "score": 37.92631, "issued": {"date-parts": [[2011, 11, 17]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2012, 1, 16]]}, "published-print": {"date-parts": [[2012, 1, 15]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-11-1270", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T09:14:13Z", "timestamp": 1574500453840}, "reference-count": 22, "publisher": "Elsevier BV", "issue": "9", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 5, 1]], "date-time": "2011-05-01T00:00:00Z", "timestamp": 1304208000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Experimental Cell Research"], "published-print": {"date-parts": [[2011, 5]]}, "DOI": "10.1016/j.yexcr.2011.03.010", "type": "journal-article", "created": {"date-parts": [[2011, 3, 17]], "date-time": "2011-03-17T08:31:58Z", "timestamp": 1300350718000}, "page": "1255-1260", "source": "Crossref", "is-referenced-by-count": 101, "title": ["Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab"], "prefix": "10.1016", "volume": "317", "author": [{"given": "Dirk", "family": "Nagorsen", "sequence": "first", "affiliation": []}, {"given": "Patrick A.", "family": "Baeuerle", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Experimental Cell Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0014482711001029?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0014482711001029?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 9]], "date-time": "2019-06-09T09:08:03Z", "timestamp": 1560071283000}, "score": 35.857635, "issued": {"date-parts": [[2011, 5]]}, "references-count": 22, "journal-issue": {"published-print": {"date-parts": [[2011, 5]]}, "issue": "9"}, "alternative-id": ["S0014482711001029"], "URL": "http://dx.doi.org/10.1016/j.yexcr.2011.03.010", "ISSN": ["0014-4827"], "issn-type": [{"value": "0014-4827", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T01:24:25Z", "timestamp": 1575249865917}, "publisher-location": "Hoboken, NJ, USA", "reference-count": 90, "publisher": "John Wiley & Sons, Inc.", "isbn-type": [{"value": "9780470646274", "type": "print"}, {"value": "9781118354599", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781118354599.ch35", "type": "book-chapter", "created": {"date-parts": [[2013, 7, 12]], "date-time": "2013-07-12T09:16:10Z", "timestamp": 1373620570000}, "page": "529-543", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Resurgence of Bispecific Antibodies"], "prefix": "10.1002", "author": [{"given": "Patrick A.", "family": "Baeuerle", "sequence": "first", "affiliation": []}, {"given": "Tobias", "family": "Raum", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2013, 2, 12]]}, "reference": [{"key": "10.1002/9781118354599.ch35-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "537", "DOI": "10.1038/305537a0", "article-title": "Hybrid hybridomas and their use in immunohistochemistry", "volume": "305", "author": "Milstein", "year": "1983", "journal-title": "Nature"}, {"key": "10.1002/9781118354599.ch35-BIB2|cit2", "first-page": "219", "article-title": "Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas. Implications for a single-step purification of bispecific antibodies", "volume": "155", "author": "Lindhofer", "year": "1995", "journal-title": "J. Immunol."}, {"key": "10.1002/9781118354599.ch35-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "2209", "DOI": "10.1002/ijc.25423", "article-title": "The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized Phase II/III trial", "volume": "127", "author": "Heiss", "year": "2010", "journal-title": "Int. J. Cancer"}, {"key": "10.1002/9781118354599.ch35-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1126/science.3925553", "article-title": "Preparation of bispecific antibodies by chemical recombination of monoclonal immunoglobulin G1 fragments", "volume": "229", "author": "Brennan", "year": "1985", "journal-title": "Science"}, {"key": "10.1002/9781118354599.ch35-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "2281", "DOI": "10.1200/JCO.1995.13.9.2281", "article-title": "Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpress the proto-oncogene HER-2/neu", "volume": "13", "author": "Valone", "year": "1995", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9781118354599.ch35-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "628", "DOI": "10.1038/314628a0", "article-title": "Hybrid antibodies can target sites for attack by T cells", "volume": "314", "author": "Staerz", "year": "1985", "journal-title": "Nature"}, {"key": "10.1002/9781118354599.ch35-BIB7|cit7", "first-page": "127", "article-title": "Construction and characterization of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids", "volume": "24", "author": "Corvalan", "year": "1987", "journal-title": "Cancer Immunol. Immunother."}, {"key": "10.1002/9781118354599.ch35-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/S0022-1759(00)00339-2", "article-title": "Bispecific human IgG by design", "volume": "248", "author": "Carter", "year": "2001", "journal-title": "J. Immunol. Methods"}, {"key": "10.1002/9781118354599.ch35-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "238", "DOI": "10.1016/j.tibtech.2004.03.006", "article-title": "A revival of bispecific antibodies", "volume": "22", "author": "Kufer", "year": "2004", "journal-title": "Trends Biotechnol."}, {"key": "10.1002/9781118354599.ch35-BIB10|cit10", "first-page": "319", "article-title": "Recombinant bispecific antibodies for cellular cancer immunotherapy", "volume": "9", "author": "M\u00fcller", "year": "2007", "journal-title": "Curr. Opin. Mol. Ther."}, {"key": "10.1002/9781118354599.ch35-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "1554", "DOI": "10.1126/science.1144603", "article-title": "Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange", "volume": "317", "author": "Van der Neut Kolfschoten", "year": "2007", "journal-title": "Science"}, {"key": "10.1002/9781118354599.ch35-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "591", "DOI": "10.1038/nature09385", "article-title": "Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation", "volume": "467", "author": "Mouquet", "year": "2010", "journal-title": "Nature"}, {"key": "10.1002/9781118354599.ch35-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1186/1756-9966-28-18", "article-title": "Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinoma-tosis", "volume": "14", "author": "Str\u00f6hlein", "year": "2009", "journal-title": "J. Exp. Clin. Cancer Res."}, {"key": "10.1002/9781118354599.ch35-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "458", "DOI": "10.1016/j.ctrv.2010.03.001", "article-title": "Development and approval of the trifunctional antibody catumaxomab (antiEpCAM x anti-CD3) as a targeted cancer immunotherapy", "volume": "36", "author": "Seimetz", "year": "2010", "journal-title": "Cancer Treat. Rev."}, {"key": "10.1002/9781118354599.ch35-BIB15|cit15", "author": "Kiewe", "volume": "12", "first-page": "3085", "year": "2008", "journal-title": "Clin. Cancer Res.", "DOI": "10.1158/1078-0432.CCR-05-2436", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118354599.ch35-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.1111/j.1365-2125.2010.03635.x", "article-title": "Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients", "volume": "69", "author": "Ruf", "year": "2010", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10.1002/9781118354599.ch35-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.1093/protein/9.7.617", "article-title": "\u201cKnobs-in-holes\u201d engineering of antibody CH3 domains for heavy chain heterodimerization", "volume": "9", "author": "Ridgway", "year": "1996", "journal-title": "Protein Eng."}, {"key": "10.1002/9781118354599.ch35-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "20850", "DOI": "10.1074/jbc.M110.113910", "article-title": "Development of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signalling", "volume": "285", "author": "Jackman", "year": "2010", "journal-title": "J. Biol. Chem."}, {"key": "10.1002/9781118354599.ch35-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "19637", "DOI": "10.1074/jbc.M110.117382", "article-title": "Enhancing antibody Fc heterodimer formation through electrostatic steering effects: applications to bispecific molecules and monovalent IgG", "volume": "285", "author": "Gunasekaran", "year": "2010", "journal-title": "J. Biol. Chem."}, {"key": "10.1002/9781118354599.ch35-BIB20|cit20", "unstructured": "Wranik B 2010 Keystone Conference on Advances in Biopharmaceuticals"}, {"key": "10.1002/9781118354599.ch35-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1093/protein/gzp094", "article-title": "SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies", "volume": "23", "author": "Davis", "year": "2010", "journal-title": "Protein Eng. Des. Sel."}, {"key": "10.1002/9781118354599.ch35-BIB22|cit22", "unstructured": "Klein C 2010 Antibody Engineering Conference"}, {"key": "10.1002/9781118354599.ch35-BIB23|cit23", "unstructured": "Throsby M 2010 Third Annual Antibody Engineering and Therapeutics Asia"}, {"key": "10.1002/9781118354599.ch35-BIB24|cit24", "unstructured": "Schuurman J 2010 Third Annual Antibody Engineering and Therapeutics Asia"}, {"key": "10.1002/9781118354599.ch35-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "544", "DOI": "10.1038/341544a0", "article-title": "Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli", "volume": "341", "author": "Ward", "year": "1989", "journal-title": "Nature"}, {"key": "10.1002/9781118354599.ch35-BIB26|cit26", "unstructured": "Hamblin P 2010"}, {"key": "10.1002/9781118354599.ch35-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "1610", "DOI": "10.1126/science.1165480", "article-title": "Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site", "volume": "323", "author": "Bostrom", "year": "2009", "journal-title": "Science"}, {"key": "10.1002/9781118354599.ch35-BIB28|cit28", "unstructured": "Fuh G 2010"}, {"key": "10.1002/9781118354599.ch35-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1016/S0921-4410(04)22013-0", "article-title": "Retargeting T cells and immune effector cells with bispecific antibodies", "volume": "22", "author": "Lum", "year": "2005", "journal-title": "Cancer Chemother. Biol. Response Modif."}, {"key": "10.1002/9781118354599.ch35-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1158/1078-0432.CCR-05-2005", "article-title": "Human T cells armed with Her2/neu bispecific antibodies divide, are cytotoxic, and secrete cytokines with repeated stimulation", "volume": "12", "author": "Grabert", "year": "2006", "journal-title": "Clin. Cancer Res."}, {"key": "10.1002/9781118354599.ch35-BIB31|cit31", "unstructured": "Lum L 2010"}, {"key": "10.1002/9781118354599.ch35-BIB32|cit32", "unstructured": "Fitzgerald K 2010"}, {"key": "10.1002/9781118354599.ch35-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "3716", "DOI": "10.1016/j.bmcl.2009.05.047", "article-title": "An efficient chemical approach to bispecific antibodies and antibodies of high valency", "volume": "19", "author": "Gavrilyuk", "year": "2009", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10.1002/9781118354599.ch35-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "1290", "DOI": "10.1038/nbt1345", "article-title": "Simultaneous targeting of multiple disease mediators by a dual-variable-domain Immunoglobulin", "volume": "25", "author": "Wu", "year": "2007", "journal-title": "Nat. Biotech."}, {"key": "10.1002/9781118354599.ch35-BIB35|cit35", "unstructured": "Ghayur T 2010"}, {"key": "10.1002/9781118354599.ch35-BIB36|cit36", "unstructured": "Ludwig D 2010"}, {"key": "10.1002/9781118354599.ch35-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1016/S0022-1759(03)00251-5", "article-title": "Di-diabody: a tetravalent bispecific antibody molecule by design", "volume": "279", "author": "Lu", "year": "2003", "journal-title": "J. Immunol. Methods"}, {"key": "10.1002/9781118354599.ch35-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1093/protein/gzp073", "article-title": "Engineering of stable bispecific antibodies targeting IL-17A and IL-23", "volume": "23", "author": "Mabry", "year": "2010", "journal-title": "Protein Eng. Des. Sel."}, {"key": "10.1002/9781118354599.ch35-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.4161/mabs.1.2.7631", "article-title": "Anti-tumor activity af stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LT-betaR", "volume": "1", "author": "Michaelson", "year": "2009", "journal-title": "MAbs"}, {"key": "10.1002/9781118354599.ch35-BIB40|cit40", "unstructured": "Scheuer W 2010"}, {"key": "10.1002/9781118354599.ch35-BIB41|cit41", "unstructured": "Dinasi N 2010"}, {"key": "10.1002/9781118354599.ch35-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1093/jb/mvj157", "article-title": "Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded bispecific antibodies linked to the antibody constant domain", "volume": "140", "author": "Natsume", "year": "2006", "journal-title": "J. Biochem."}, {"key": "10.1002/9781118354599.ch35-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "1744", "DOI": "10.4161/cbt.7.11.6725", "article-title": "In vitro and in vivo antitumor effect of a trivalent bispecific antibody targeting ErbB2 and CD16", "volume": "7", "author": "Lu", "year": "2008", "journal-title": "Cancer Biol. Ther."}, {"key": "10.1002/9781118354599.ch35-BIB44|cit44", "unstructured": "Blankenship JW Strobel S Tan P Grosmaire L Simon A Clark C 2009 Anti-CD79B \u00d7 anti-DR SCORPION molecule: A single chain, bispecific immunotherapeutic with potent in vitro activity against B-cell lymphoma"}, {"key": "10.1002/9781118354599.ch35-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.4161/mabs.2.1.10498", "article-title": "A dual-targeting PDGFRbeta/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo", "volume": "2", "author": "Mabry", "year": "2010", "journal-title": "MAbs"}, {"key": "10.1002/9781118354599.ch35-BIB46|cit46", "unstructured": "Johnson S 2010"}, {"key": "10.1002/9781118354599.ch35-BIB47|cit47", "unstructured": "Guo J 2010"}, {"key": "10.1002/9781118354599.ch35-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "715", "DOI": "10.1038/nri2155", "article-title": "FcRn: the neonatal Fc receptor comes of age", "volume": "7", "author": "Roopenian", "year": "2007", "journal-title": "Nat. Rev. Immunol."}, {"key": "10.1002/9781118354599.ch35-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1038/nri2206", "article-title": "Fcgamma receptors as regulators of immune responses", "volume": "8", "author": "Nimmerjahn", "year": "2008", "journal-title": "Nat. Rev. Immunol."}, {"key": "10.1002/9781118354599.ch35-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "1637", "DOI": "10.1007/s00262-007-0310-7", "article-title": "Treatment of non-small cell lung cancer oatients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM \u00d7 anti-CD3): a Phase I study", "volume": "56", "author": "Sebastian", "year": "2007", "journal-title": "Cancer Immunol. Immunother."}, {"key": "10.1002/9781118354599.ch35-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "4005", "DOI": "10.1073/pnas.0508123103", "article-title": "Engineered antibody Fc variants with enhanced effector function", "volume": "103", "author": "Lazar", "year": "2006", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10.1002/9781118354599.ch35-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "170", "DOI": "10.1002/cncr.22402", "article-title": "Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors", "volume": "109", "author": "Beckman", "year": "2007", "journal-title": "Cancer"}, {"key": "10.1002/9781118354599.ch35-BIB53|cit53", "unstructured": "Sheer J 2010"}, {"key": "10.1002/9781118354599.ch35-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "6161", "DOI": "10.1182/blood-2008-10-187138", "article-title": "Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma", "volume": "113", "author": "Rossi", "year": "2009", "journal-title": "Blood"}, {"key": "10.1002/9781118354599.ch35-BIB55|cit55", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1053/j.semnuclmed.2009.12.002", "article-title": "Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radio-immunotherapy", "volume": "40", "author": "Sharkey", "year": "2010", "journal-title": "Semin. Nucl. Med."}, {"key": "10.1002/9781118354599.ch35-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "7050", "DOI": "10.4049/jimmunol.165.12.7050", "article-title": "Fab chains as an efficient heterodimerization domain scaffold for the production of recombinant bispecific and trispecific antibody derivatives", "volume": "165", "author": "Schoonjans", "year": "2000", "journal-title": "J. Immunol."}, {"key": "10.1002/9781118354599.ch35-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1097/01.cji.0000210080.60178.fd", "article-title": "Anti-tumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to EpCAM expressing tumor cells", "volume": "29", "author": "Schanzer", "year": "2006", "journal-title": "J. Immunother."}, {"key": "10.1002/9781118354599.ch35-BIB58|cit58", "unstructured": "Humphreys D 2010"}, {"key": "10.1002/9781118354599.ch35-BIB59|cit59", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.4161/mabs.2.1.10786", "article-title": "Antibody fragments: hope and hype", "volume": "2", "author": "Nelson", "year": "2010", "journal-title": "MAbs"}, {"key": "10.1002/9781118354599.ch35-BIB60|cit60", "first-page": "543", "article-title": "Therapeutic bispecific antibodies: the selection of stable single-chain fragments to overcome engineering obstacles", "volume": "13", "author": "Mabry", "year": "2010", "journal-title": "IDrugs"}, {"key": "10.1002/9781118354599.ch35-BIB61|cit61", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1016/0076-6879(91)03005-2", "article-title": "Protein engineering of single-chain Fv analogs and fusion proteins", "volume": "203", "author": "Huston", "year": "1991", "journal-title": "Methods Enzymol."}, {"key": "10.1002/9781118354599.ch35-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/S0022-1759(00)00342-2", "article-title": "Design and application of diabodies, triabodies and tetrabodies for cancer targeting", "volume": "248", "author": "Todorovska", "year": "2001", "journal-title": "J. Immunol. Methods"}, {"key": "10.1002/9781118354599.ch35-BIB63|cit63", "first-page": "22", "article-title": "BiTE: teaching antibodies to engage T-cells for cancer therapy", "volume": "11", "author": "Baeuerle", "year": "2009", "journal-title": "Curr. Opin. Mol. Ther."}, {"key": "10.1002/9781118354599.ch35-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "4941", "DOI": "10.1158/0008-5472.CAN-09-0547", "article-title": "Bispecific T-cell engaging antibodies for cancer therapy", "volume": "69", "author": "Baeuerle", "year": "2009", "journal-title": "Cancer Res."}, {"key": "10.1002/9781118354599.ch35-BIB65|cit65", "author": "Handgretinger", "year": "2010", "article-title": "Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia", "journal-title": "Leukemia"}, {"key": "10.1002/9781118354599.ch35-BIB66|cit66", "doi-asserted-by": "crossref", "first-page": "974", "DOI": "10.1126/science.1158545", "article-title": "Tumor regression in cancer patients by very low doses of a T cell-engaging antibody", "volume": "321", "author": "Bargou", "year": "2008", "journal-title": "Science"}, {"key": "10.1002/9781118354599.ch35-BIB67|cit67", "doi-asserted-by": "crossref", "first-page": "879", "DOI": "10.1111/j.1365-2141.2009.08033.x", "article-title": "Novel conjugates of single-chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells", "volume": "148", "author": "Stein", "year": "2010", "journal-title": "Br. J. Haematol."}, {"key": "10.1002/9781118354599.ch35-BIB68|cit68", "unstructured": "Schubert I Kellner C Stein C K\u00fcgler M Schwenkert M Saul D 2011 A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting", "DOI": "10.4161/mabs.3.1.14057", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118354599.ch35-BIB69|cit69", "doi-asserted-by": "crossref", "first-page": "1210", "DOI": "10.4049/jimmunol.0902033", "article-title": "A recombinant bispecific single-chain fragmentr variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells", "volume": "184", "author": "Guettinger", "year": "2010", "journal-title": "J. Immunol."}, {"key": "10.1002/9781118354599.ch35-BIB70|cit70", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1093/protein/gzh039", "article-title": "Effect of linker sequences between the antibody variable domains on the formation, stability, and biological activity of a bispecific tandem diabody", "volume": "17", "author": "Le Gall", "year": "2004", "journal-title": "Protein Eng. Des. Sel."}, {"key": "10.1002/9781118354599.ch35-BIB71|cit71", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1002/ijc.20417", "article-title": "Effect of tetravalent bispecific CD19\u00d7CD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells", "volume": "112", "author": "reusch", "year": "2004", "journal-title": "Int. J. Cancer"}, {"key": "10.1002/9781118354599.ch35-BIB72|cit72", "first-page": "2562", "article-title": "A bispecific diabody that mediates natural killer cell cytotoxicity against xenotransplanted human Hodgkin's tumors", "volume": "94", "author": "Arndt", "year": "1999", "journal-title": "Blood"}, {"key": "10.1002/9781118354599.ch35-BIB73|cit73", "first-page": "4336", "article-title": "Cure of Burkitt's lymphoma in severe combined immunodeficiency mice by T cells, tetravalent CD3 \u00d7 CD19 tandem diabody, and CD28 costimulation", "volume": "60", "author": "Cochlovius", "year": "2000", "journal-title": "Cancer Res."}, {"key": "10.1002/9781118354599.ch35-BIB74|cit74", "doi-asserted-by": "crossref", "first-page": "436", "DOI": "10.1016/j.jmb.2010.04.001", "article-title": "Effector cell recruitment with novel Fv-based dual-affinity retargeting proteins leads to potent tumor cytolysis and in vivo B-cell depletion", "volume": "399", "author": "Johnson", "year": "2010", "journal-title": "J. Mol. Biol."}, {"key": "10.1002/9781118354599.ch35-BIB75|cit75", "first-page": "1933", "article-title": "Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold", "volume": "62", "author": "Veri", "year": "2010", "journal-title": "Arthritis Rheum."}, {"key": "10.1002/9781118354599.ch35-BIB76|cit76", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1016/j.jim.2007.09.003", "article-title": "Validation of a stable recombinant antibodies repertoire for the direct selection of functional intracellular reagents", "volume": "329", "author": "Villani", "year": "2008", "journal-title": "J. Immunol. Methods"}, {"key": "10.1002/9781118354599.ch35-BIB77|cit77", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1093/protein/gzq058", "article-title": "The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion protein", "volume": "23", "author": "Hopp", "year": "2010", "journal-title": "Protein Eng. Des. Sel."}, {"key": "10.1002/9781118354599.ch35-BIB78|cit78", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1586/14737140.5.3.523", "article-title": "T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy", "volume": "5", "author": "Noy", "year": "2005", "journal-title": "Expert Rev. Anticancer Ther."}, {"key": "10.1002/9781118354599.ch35-BIB79|cit79", "unstructured": "Drummond D 2010"}, {"key": "10.1002/9781118354599.ch35-BIB80|cit80", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.1038/icb.2010.21", "article-title": "COMBODY: one-domain antibody multimer with improved avidity", "volume": "88", "author": "Zhu", "year": "2010", "journal-title": "Immunol. Cell Biol."}, {"key": "10.1002/9781118354599.ch35-BIB81|cit81", "author": "Shusterman", "year": "2010", "article-title": "Antitumor activity of Hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a children's oncology group (COG) Phase II study", "journal-title": "J. Clin. Oncol.", "DOI": "10.1200/JCO.2009.27.8861", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118354599.ch35-BIB82|cit82", "author": "Johannsen", "volume": "46", "first-page": "2926", "year": "2010", "journal-title": "Eur. J. Cancer", "DOI": "10.1016/j.ejca.2010.07.033", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118354599.ch35-BIB83|cit83", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1517/14712590903575620", "article-title": "Naptumomab estefenatox: a new immunoconjugate", "volume": "10", "author": "Robinson", "year": "2010", "journal-title": "Expert Opin. Biol. Ther."}, {"key": "10.1002/9781118354599.ch35-BIB84|cit84", "doi-asserted-by": "crossref", "first-page": "602", "DOI": "10.1200/JCO.2004.12.034", "article-title": "Individualized patient dosing in Phase I clinical trials: the role of escalation with overdose control in PNU-214936", "volume": "22", "author": "Cheng", "year": "2004", "journal-title": "J. Clin. Oncol."}, {"key": "10.1002/9781118354599.ch35-BIB85|cit85", "doi-asserted-by": "crossref", "first-page": "140", "DOI": "10.1007/s12033-010-9250-0", "article-title": "Production of a soluble disulfide-linked TCR in the cytoplasm of Escherichia coli trxB got mutants", "volume": "45", "author": "Liddy", "year": "2010", "journal-title": "Mol. Biotechnol."}, {"key": "10.1002/9781118354599.ch35-BIB86|cit86", "doi-asserted-by": "crossref", "first-page": "1239", "DOI": "10.1016/j.jmb.2004.01.007", "article-title": "Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa", "volume": "336", "author": "Okazaki", "year": "2004", "journal-title": "J. Mol. Biol."}, {"key": "10.1002/9781118354599.ch35-BIB87|cit87", "doi-asserted-by": "crossref", "first-page": "499", "DOI": "10.1586/eci.09.31", "article-title": "Monoclonal antibody-induced cytokine-release syndrome", "volume": "5", "author": "Bugelski", "year": "2009", "journal-title": "Expert Rev. Clin. Immunol."}, {"key": "10.1002/9781118354599.ch35-BIB88|cit88", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1016/S0167-5699(05)80043-X", "article-title": "Staphylococcalenterotoxin-dependent cell-mediated cytotoxicity", "volume": "12", "author": "Dohlsten", "year": "1991", "journal-title": "Immunol. Today"}, {"key": "10.1002/9781118354599.ch35-BIB89|cit89", "doi-asserted-by": "crossref", "first-page": "12605", "DOI": "10.1073/pnas.1000976107", "article-title": "T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells", "volume": "107", "author": "Lutterbuese", "year": "2010", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10.1002/9781118354599.ch35-BIB90|cit90", "doi-asserted-by": "crossref", "first-page": "524", "DOI": "10.1038/ni1058", "article-title": "T cell killing does not require the formation of a stable mature immunological synapse", "volume": "5", "author": "Purbhoo", "year": "2004", "journal-title": "Nat. Immunol."}], "container-title": ["Fusion Protein Technologies for Biopharmaceuticals"], "deposited": {"date-parts": [[2019, 7, 18]], "date-time": "2019-07-18T02:54:37Z", "timestamp": 1563418477000}, "score": 32.296684, "issued": {"date-parts": [[2013, 2, 12]]}, "ISBN": ["9781118354599", "9780470646274"], "references-count": 90, "URL": "http://dx.doi.org/10.1002/9781118354599.ch35", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:40:40Z", "timestamp": 1574116840542}, "reference-count": 84, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 5, 1]], "date-time": "2004-05-01T00:00:00Z", "timestamp": 1083369600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Trends in Biotechnology"], "published-print": {"date-parts": [[2004, 5]]}, "DOI": "10.1016/j.tibtech.2004.03.006", "type": "journal-article", "created": {"date-parts": [[2004, 4, 3]], "date-time": "2004-04-03T10:19:42Z", "timestamp": 1080987582000}, "page": "238-244", "source": "Crossref", "is-referenced-by-count": 104, "title": ["A revival of bispecific antibodies"], "prefix": "10.1016", "volume": "22", "author": [{"given": "Peter", "family": "Kufer", "sequence": "first", "affiliation": []}, {"given": "Ralf", "family": "Lutterb\u00fcse", "sequence": "additional", "affiliation": []}, {"given": "Patrick A.", "family": "Baeuerle", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Trends in Biotechnology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0167779904000800?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0167779904000800?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 14]], "date-time": "2019-02-14T07:56:19Z", "timestamp": 1550130979000}, "score": 30.86392, "issued": {"date-parts": [[2004, 5]]}, "references-count": 84, "journal-issue": {"published-print": {"date-parts": [[2004, 5]]}, "issue": "5"}, "alternative-id": ["S0167779904000800"], "URL": "http://dx.doi.org/10.1016/j.tibtech.2004.03.006", "ISSN": ["0167-7799"], "issn-type": [{"value": "0167-7799", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T15:43:12Z", "timestamp": 1575214992308}, "reference-count": 58, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 6, 1]], "date-time": "2013-06-01T00:00:00Z", "timestamp": 1370044800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Chemical Biology"], "published-print": {"date-parts": [[2013, 6]]}, "DOI": "10.1016/j.cbpa.2013.03.029", "type": "journal-article", "created": {"date-parts": [[2013, 4, 26]], "date-time": "2013-04-26T02:25:06Z", "timestamp": 1366943106000}, "page": "385-392", "source": "Crossref", "is-referenced-by-count": 91, "title": ["Targeting T cells to tumor cells using bispecific antibodies"], "prefix": "10.1016", "volume": "17", "author": [{"given": "Stanley R", "family": "Frankel", "sequence": "first", "affiliation": []}, {"given": "Patrick A", "family": "Baeuerle", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Current Opinion in Chemical Biology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1367593113000549?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1367593113000549?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 16]], "date-time": "2018-10-16T14:27:11Z", "timestamp": 1539700031000}, "score": 28.245796, "issued": {"date-parts": [[2013, 6]]}, "references-count": 58, "journal-issue": {"published-print": {"date-parts": [[2013, 6]]}, "issue": "3"}, "alternative-id": ["S1367593113000549"], "URL": "http://dx.doi.org/10.1016/j.cbpa.2013.03.029", "ISSN": ["1367-5931"], "issn-type": [{"value": "1367-5931", "type": "print"}], "subject": ["Analytical Chemistry", "Biochemistry"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T10:25:18Z", "timestamp": 1574159118832}, "reference-count": 0, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4466, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int. J. Cancer"], "published-print": {"date-parts": [[2003, 6, 10]]}, "DOI": "10.1002/ijc.11056", "type": "journal-article", "created": {"date-parts": [[2003, 4, 2]], "date-time": "2003-04-02T17:37:48Z", "timestamp": 1049305068000}, "page": "241-248", "source": "Crossref", "is-referenced-by-count": 20, "title": ["Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody"], "prefix": "10.1002", "volume": "105", "author": [{"given": "Pauline", "family": "Wimberger", "sequence": "first", "affiliation": []}, {"given": "Wei", "family": "Xiang", "sequence": "additional", "affiliation": []}, {"given": "Doris", "family": "Mayr", "sequence": "additional", "affiliation": []}, {"given": "Joachim", "family": "Diebold", "sequence": "additional", "affiliation": []}, {"given": "Torsten", "family": "Dreier", "sequence": "additional", "affiliation": []}, {"given": "Patrick A.", "family": "Baeuerle", "sequence": "additional", "affiliation": []}, {"given": "Rainer", "family": "Kimmig", "sequence": "additional", "affiliation": []}], "member": "311", "container-title": ["International Journal of Cancer"], "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.11056", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.11056", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 4]], "date-time": "2018-08-04T02:24:46Z", "timestamp": 1533349486000}, "score": 24.327488, "issued": {"date-parts": [[2003, 6, 10]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.1002/ijc.11056", "ISSN": ["0020-7136", "1097-0215"], "issn-type": [{"value": "0020-7136", "type": "print"}, {"value": "1097-0215", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T13:17:44Z", "timestamp": 1575206264036}, "reference-count": 0, "publisher": "Austin Publishing Group", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gastrointest Cancer Res Ther"], "published-print": {"date-parts": [[2017, 5, 4]]}, "DOI": "10.26420/gastrointestcancerresther.2017.1018", "type": "journal-article", "created": {"date-parts": [[2017, 12, 14]], "date-time": "2017-12-14T09:30:21Z", "timestamp": 1513243821000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Prognostic Significance of Deprivation in Upper Gastrointestinal Cancer"], "prefix": "10.26420", "volume": "2", "author": [{"given": "Blake", "family": "PA", "sequence": "first", "affiliation": []}], "member": "10954", "container-title": ["Gastrointestinal Cancer: Research & Therapy"], "deposited": {"date-parts": [[2017, 12, 14]], "date-time": "2017-12-14T09:30:21Z", "timestamp": 1513243821000}, "score": 23.904861, "issued": {"date-parts": [[2017, 5, 4]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2017, 7, 17]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.26420/gastrointestcancerresther.2017.1018", "ISSN": ["2574-2949"], "issn-type": [{"value": "2574-2949", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T01:54:09Z", "timestamp": 1574128449769}, "reference-count": 33, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 7, 1]], "date-time": "2004-07-01T00:00:00Z", "timestamp": 1088640000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Immunology"], "published-print": {"date-parts": [[2004, 7]]}, "DOI": "10.1016/j.molimm.2004.04.002", "type": "journal-article", "created": {"date-parts": [[2004, 5, 30]], "date-time": "2004-05-30T02:39:31Z", "timestamp": 1085884771000}, "page": "511-518", "source": "Crossref", "is-referenced-by-count": 2, "title": ["A bispecific single-chain antibody fusion protein for targeted depletion of autoreactive B cells via unstimulated human T lymphocytes"], "prefix": "10.1016", "volume": "41", "author": [{"given": "Marcel", "family": "Zocher", "sequence": "first", "affiliation": []}, {"given": "Patrick A.", "family": "Baeuerle", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Molecular Immunology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0161589004001075?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0161589004001075?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 7]], "date-time": "2019-02-07T16:58:17Z", "timestamp": 1549558697000}, "score": 23.566418, "issued": {"date-parts": [[2004, 7]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[2004, 7]]}, "issue": "5"}, "alternative-id": ["S0161589004001075"], "URL": "http://dx.doi.org/10.1016/j.molimm.2004.04.002", "ISSN": ["0161-5890"], "issn-type": [{"value": "0161-5890", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T16:26:54Z", "timestamp": 1574094414843}, "reference-count": 6, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 3, 1]], "date-time": "2002-03-01T00:00:00Z", "timestamp": 1014940800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today"], "published-print": {"date-parts": [[2002, 3]]}, "DOI": "10.1016/s1359-6446(01)02166-3", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T11:46:33Z", "timestamp": 1027597593000}, "page": "S25-S27", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Micromet: engaging immune cells for life"], "prefix": "10.1016", "volume": "7", "author": [{"given": "Evelyn", "family": "Wolf", "sequence": "first", "affiliation": []}, {"given": "Patrick A.", "family": "Baeuerle", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359644601021663?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359644601021663?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 1]], "date-time": "2019-05-01T11:30:40Z", "timestamp": 1556710240000}, "score": 23.153347, "issued": {"date-parts": [[2002, 3]]}, "references-count": 6, "journal-issue": {"published-print": {"date-parts": [[2002, 3]]}, "issue": "5"}, "alternative-id": ["S1359644601021663"], "URL": "http://dx.doi.org/10.1016/s1359-6446(01)02166-3", "ISSN": ["1359-6446"], "issn-type": [{"value": "1359-6446", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T12:24:59Z", "timestamp": 1574252699352}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "12", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 11, 1]], "date-time": "2006-11-01T00:00:00Z", "timestamp": 1162339200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer Supplements"], "published-print": {"date-parts": [[2006, 11]]}, "DOI": "10.1016/s1359-6349(06)70229-4", "type": "journal-article", "created": {"date-parts": [[2006, 12, 22]], "date-time": "2006-12-22T22:36:58Z", "timestamp": 1166827018000}, "page": "70", "source": "Crossref", "is-referenced-by-count": 0, "title": ["224 POSTER Characterization of a murine EpCAM/CD3-bispecific BiTE molecule as a surrogate for preclinical development of the human EpCAM/CD3-bispecific BiTE molecule MT110"], "prefix": "10.1016", "volume": "4", "author": [{"given": "B.", "family": "Schlereth", "sequence": "first", "affiliation": []}, {"given": "K.", "family": "Brischwein", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Lutterbuese", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Parr", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Lorenczewski", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Aman", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Kischel", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Kufer", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Locher", "sequence": "additional", "affiliation": []}, {"given": "P.A.", "family": "Baeuerle", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359634906702294?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359634906702294?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 10]], "date-time": "2019-01-10T15:57:33Z", "timestamp": 1547135853000}, "score": 23.066647, "issued": {"date-parts": [[2006, 11]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 11]]}, "issue": "12"}, "alternative-id": ["S1359634906702294"], "URL": "http://dx.doi.org/10.1016/s1359-6349(06)70229-4", "ISSN": ["1359-6349"], "issn-type": [{"value": "1359-6349", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T13:17:49Z", "timestamp": 1575206269013}, "reference-count": 0, "publisher": "Austin Publishing Group", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gastrointest Cancer Res Ther"], "published-print": {"date-parts": [[2017, 6, 5]]}, "DOI": "10.26420/austinjgastroenterol.2017.1021", "type": "journal-article", "created": {"date-parts": [[2017, 12, 14]], "date-time": "2017-12-14T09:43:08Z", "timestamp": 1513244588000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Prognostic Significance of Diagnostic Delay and Deprivation in the Management of Upper Gastrointestinal Cancer"], "prefix": "10.26420", "volume": "2", "author": [{"given": "Blake", "family": "PA", "sequence": "first", "affiliation": []}], "member": "10954", "container-title": ["Gastrointestinal Cancer: Research & Therapy"], "deposited": {"date-parts": [[2017, 12, 14]], "date-time": "2017-12-14T09:43:08Z", "timestamp": 1513244588000}, "score": 22.669151, "issued": {"date-parts": [[2017, 6, 5]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2017, 7, 17]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.26420/austinjgastroenterol.2017.1021", "ISSN": ["2574-2949"], "issn-type": [{"value": "2574-2949", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T00:44:13Z", "timestamp": 1575247453564}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2018, 2, 15]]}, "DOI": "10.1158/1538-7445.sabcs17-cs1-1", "type": "proceedings-article", "created": {"date-parts": [[2018, 2, 15]], "date-time": "2018-02-15T17:58:14Z", "timestamp": 1518717494000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract CS1-1: Adjuvant endocrine therapy for premenopausal ER+ breast cancer"], "prefix": "10.1158", "author": [{"given": "PA", "family": "Francis", "sequence": "first", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2018, 2, 14]]}, "event": {"name": "Abstracts: 2017 San Antonio Breast Cancer Symposium; December 5-9, 2017; San Antonio, Texas"}, "container-title": ["Invited Speaker Abstracts"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.SABCS17-CS1-1", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 20]], "date-time": "2019-05-20T12:53:32Z", "timestamp": 1558356812000}, "score": 22.613792, "issued": {"date-parts": [[2018, 2, 14]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.SABCS17-CS1-1"], "URL": "http://dx.doi.org/10.1158/1538-7445.sabcs17-cs1-1"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:02:48Z", "timestamp": 1574488968033}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "6", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1988, 12, 1]], "date-time": "1988-12-01T00:00:00Z", "timestamp": 596937600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1988, 12]]}, "DOI": "10.1038/bjc.1988.302", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T10:35:25Z", "timestamp": 1295001325000}, "page": "746-752", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Sensitivity of locally recurrent rat mammary tumour cell lines to syngeneic polymorphonuclear cell, macrophage and natural killer cell cytolysis"], "prefix": "10.1038", "volume": "58", "author": [{"given": "PA", "family": "Aeed", "sequence": "first", "affiliation": []}, {"given": "DR", "family": "Welch", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc1988302.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1988302", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1988302.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 13]], "date-time": "2019-03-13T14:06:32Z", "timestamp": 1552485992000}, "score": 22.4989, "issued": {"date-parts": [[1988, 12]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1988, 12]]}, "issue": "6"}, "alternative-id": ["BFbjc1988302"], "URL": "http://dx.doi.org/10.1038/bjc.1988.302", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T11:15:53Z", "timestamp": 1575458153250}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Cancer Therapeutics"], "published-print": {"date-parts": [[2014, 6, 1]]}, "DOI": "10.1158/1535-7163.mct-13-0956", "type": "journal-article", "created": {"date-parts": [[2014, 3, 28]], "date-time": "2014-03-28T08:38:13Z", "timestamp": 1395995893000}, "page": "1549-1557", "source": "Crossref", "is-referenced-by-count": 57, "title": ["Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell-Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia"], "prefix": "10.1158", "volume": "13", "author": [{"given": "M.", "family": "Friedrich", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Henn", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Raum", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Bajtus", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Matthes", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Hendrich", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Wahl", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Hoffmann", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Kischel", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Kvesic", "sequence": "additional", "affiliation": []}, {"given": "J. W.", "family": "Slootstra", "sequence": "additional", "affiliation": []}, {"given": "P. A.", "family": "Baeuerle", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Kufer", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Rattel", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 3, 27]]}, "container-title": ["Molecular Cancer Therapeutics"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1535-7163.MCT-13-0956", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 22]], "date-time": "2016-12-22T23:40:39Z", "timestamp": 1482450039000}, "score": 22.476952, "issued": {"date-parts": [[2014, 3, 27]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 6, 4]]}, "published-print": {"date-parts": [[2014, 6, 1]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1158/1535-7163.mct-13-0956", "ISSN": ["1535-7163", "1538-8514"], "issn-type": [{"value": "1535-7163", "type": "print"}, {"value": "1538-8514", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}